|
'Chitosan (1) | 1 (2) | 1, 3, 4 - oxadiazoles (1) |
1,2,3,4-tetrahydro-9Hpyrido [3,4-b] indole-3-carboxylic acid (1) | 1,3,4-Oxadiazole (1) | 1,3,4-Oxadiazoles (1) |
1-butyl-3-methyl imidazolium bromide (1) | 1-butyl-3-methyl imidazolium chloride. (1) | 1-methyl-4-phenyl-1 (1) |
12-Dimethylbenz[a]anthracene (1) | 18 β-glycyrrhetic acid (1) | 2 (2) |
2, 5-diaza bicyclo [4.3.1] compounds (1) | 2,2-diphenyl-1-picrylhdrazyl (1) | 2-(N-hydroxymethyl amino)-indol-3-yl-propanoic acid (1) |
2-aminobenzothiazole (1) | 2-Hydroxypropyl-β-cyclodextrin (1) | 23 factorial design (1) |
25(OH)2D (1) | 3 (2) | 3-Methyl-2-benzothiazonium hydrazone hydrochloride (1) |
32 factorial design (1) | 3CLPRO (1) | 3D printing (1) |
3D bio-ink printing (1) | 3D QSAR (1) | 3D-QSAR (1) |
3’ UTR region (1) | 4 - acetamido phenoxy acetyl hydrazide (1) | 4-dihydroxy-4-methoxybenzophenone- 2-O-β-d-glucopyranoside (1) |
4-pyridinecarboxylic acid hydrazide (1) | 4-Thiadiazole-2-amine (1) | 5-fluoroindolin-2-one (1) |
5-Fluorouracil (1) | 5-HT 3 receptor antagonists (1) | 5-Piperazinedione (1) |
6 (1) | 6-beta naltrexol (1) | 6-Mercaptopurine (1) |
6-Methylmercaptopurine (1) | 6-tetrahydropyridine (MPTP) (1) | 7 (1) |
7-Hydroxy warfarin. (1) | 8-iso-Prostaglandin F2α (1) | 99mTc-ciprofloxacin (1) |
A. nilotica (1) | ABC analysis (5) | ABC-VED matrix (4) |
ABC-VEN analysis (1) | Abdominal pain (1) | Abdominal Pregnancy (1) |
Abheshaja (1) | Absorbance ratio (1) | Absorption ratio (1) |
Abstinence (1) | ABTS (1) | Abuse (1) |
Acacetin (1) | Academic Stressors scale (1) | Acalypha indica (1) |
Acarbose (1) | Accuracy. (1) | Accurate (1) |
ACE (2) | ACE inhibitor (1) | ACE2 receptor (1) |
Aceclofenac (1) | ACEIs (1) | Acetaminophen (2) |
Acetazolamide (1) | Acetic acid induced rat colitis (1) | acetic acid induced writhing test (1) |
Acetyl cholinesterase estimation (1) | Acetyl isoniazid (1) | Acetylation rate (1) |
Acetylcholinesterase (5) | Acetylcholinesterase inhibitors (1) | ACF (1) |
Achillea millefolium L. (2) | Acid hydrolysis (1) | Acid violet 43 (1) |
Acid-resistant capsules (1) | Acne (2) | Acne vulgaris (1) |
Aconitine (1) | Acquired immune deÞ ciency syndrome (1) | Acrylamide grafted ghatti gum; Biodegradable; Diclofenac sodium; pH-sensitive hydrogel; Controlled-release. (1) |
Act score (1) | ACTD (1) | Actinomycetes (1) |
Activator procaspase-3 (1) | Active metabolites (2) | active pharmaceutical ingredient (1) |
Active site (1) | Activities of daily living (ADL) scale (1) | Activity domain (1) |
Acupuncture (1) | Acute appendicitis (1) | Acute generalized exanthematous pustulosis (1) |
Acute Inflammation (1) | Acute inß ammation (1) | Acute Kidney Damage (1) |
Acute poisoning (1) | Acute renal failure (1) | Acute Severe Pancreatitis (1) |
Acute Side Effects (1) | Acute ST segment elevation myocardial infarction (1) | Acute toxicity (2) |
acyclovir (2) | Adapalene (1) | ADE (1) |
Adenanthera (1) | Adenosine A 2A antagonist (1) | Adherence (5) |
Adherence. (1) | Adiantum venustum (1) | Adjuvant therapy (2) |
ADME properties. (1) | Adnexal masses (1) | ADR (2) |
ADR (Adverse Drug Reaction) (3) | ADR management (1) | ADR monitoring centre (AMC). (1) |
ADR reporting (1) | ADR(Adverse Drug Reaction) (1) | ADRs (2) |
Adsorbent (1) | Adults. (1) | Adverse drug event (1) |
adverse drug events (1) | Adverse drug reaction (16) | Adverse Drug Reaction (ADR) (1) |
Adverse Drug Reaction and Antihypertensive medications. (1) | Adverse Drug Reaction Reporting Systems (2) | Adverse drug reaction. (1) |
Adverse Drug Reactions (10) | Adverse drug reactions (ADRs) (1) | Adverse effects (1) |
Adverse event following immunization (AEFI) (1) | Adverse events (2) | Adverse reaction (1) |
Aedes aegypti (2) | Aedes aegypti L (1) | Aedes albopictus (1) |
Aerobic exercise (1) | Aerosil (1) | affective ; assessment ; cognitive ; learning domains ; psychomotor (1) |
Age (2) | Aged People (1) | Ageratum conyzoides L (1) |
Agrobacterium (1) | air pollution (1) | Airjet (1) |
Albendazole (1) | Albino mice (1) | Albino wistar rats (1) |
Albumin Denaturation (1) | Alcohol (4) | Alcohol withdrawl seizure (1) |
alcoholic extract (1) | ALDEN (1) | Aldose reductase inhibitors (1) |
Alkaloids (1) | allantoin (1) | Allergic reactions (1) |
Allergic rhinitis (1) | Allergy (4) | Allium sativum (1) |
Alloxan (1) | Alloxan monohydrate (1) | Alocasia indica Schott (1) |
Aloe vera (1) | Alpha mangostin (1) | Alpha-adrenoceptor (1) |
alpha-delta-bungarotoxin-4 (1) | Alpinia speciosa (1) | Alprazolam (1) |
Alteration of drug cost (1) | Altered Mental Status (AMS) (1) | Alternative medications (1) |
alternative therapy (1) | Altmetric (1) | Aluminium chloride (2) |
Alzheimer's disease (1) | Alzheimers disease (1) | Alzheimer’s disease (3) |
Amaranthus spinosus Linn (1) | Amber (1) | Ambroxol hydrochloride (1) |
Ambulatorial Surgery Procedures (1) | Ambulatory patients. (1) | Amides (1) |
Amikacin Sulfate (1) | Amino acids (1) | amino benzylated Mannich bases (1) |
Amisulpride (1) | amivudine (1) | Amlodipine (2) |
Amlodipine besylate (2) | Ammonium salts (1) | Amoora cucullata. (1) |
amoxicillin (1) | Amoxicillin - clavulanic acid (1) | Amoxicillin sodium (1) |
Amphotericin B (1) | Amrād Wabā’ī (1) | Anabolic steroids (1) |
Anabolic. (1) | Anaemia (2) | Analgesia (1) |
analgesic (10) | Analgesic effect (1) | analgesic- anti-inß ammatory activity (1) |
Analgesics (1) | Analysis in capsules (1) | Analysis of variance (1) |
Analytical methods (1) | Anaphylactic shock (1) | Anaphylaxis. (1) |
and TGF–β (1) | Andragogy (1) | Andrographolide (1) |
Anemia (3) | Anethole (1) | Anethum graveolens (1) |
Aneurysm (1) | Angiogenesis (1) | Angiogenic growth factors (1) |
Angiotensin Converting Enzyme Inhibitors (1) | Animal model (1) | Animal Models (1) |
Ankylosing spondylitis (1) | antepartum (1) | anthelmintic (1) |
anthelmintic property (1) | Anthocyanin (1) | Anthracyclines (2) |
Anti aging (1) | Anti hyperglycemic (1) | Anti inflammatory (1) |
Anti-amnesia (2) | anti-anxiety activity (2) | Anti-anxiolytic (1) |
Anti-asthmatic activity (1) | Anti-Cancer Activity (1) | Anti-diabetes mellitus. (1) |
Anti-diabetic drugs (1) | Anti-diabetics (1) | Anti-eczema drugs (1) |
Anti-epileptic (1) | Anti-epileptic drugs utilization (1) | Anti-HIV (2) |
anti-hypertensive agent (1) | Anti-infective (2) | Anti-infective agents (1) |
anti-inflammation (1) | anti-inflammatory (7) | Anti-inflammatory Activities of Total Leaf Extracts of Ficus sycomorus L. (Moraceae) used in Traditional Medicine in the Treatment of Sickle Cell Disease (1) |
anti-inflammatory activity (2) | anti-inflammatory activity', (1) | anti-inflammatory agent (1) |
anti-inß ammatory (3) | Anti-inß ammatory activity (1) | Anti-obesity (1) |
Anti-oxidant (2) | Anti-parkinsonism activity (1) | Anti-solvent (1) |
anti-spasmodic drug (1) | Anti-TB drugs (1) | Anti-tubercular activity (1) |
Anti-tumor agent (1) | antiamnesic agents (1) | Antianxiety (1) |
antibacterial (3) | antibacterial activity (5) | Antibacterial drugs (1) |
Antibiotic (2) | Antibiotic Drug utilization (1) | antibiotic guidelines (1) |
Antibiotic paste (1) | Antibiotic Resistance (5) | Antibiotic Sensitivity (1) |
Antibiotic stewardship (1) | Antibiotics (13) | Antibiotics. (1) |
Anticancer (6) | Anticancer activity (1) | Anticancer drugs (1) |
Anticholinergic (1) | Anticoagulant (3) | Anticoagulant service (1) |
anticonvulsant (1) | anticonvulsant activity (1) | anticonvulsants (1) |
Anticovulsant (1) | Antidepressants (1) | Antidesma bunius (1) |
Antidiabetic (3) | Antidiabetic activity (2) | Antidiabetic agents (1) |
Antiepileptic (1) | antiepileptic agents (1) | Antiepileptic Drugs (3) |
Antifibrinolytic. (1) | antifungal (1) | antifungal activity (1) |
Antifungal drugs (1) | Antigen (1) | antigen protein (1) |
Antiglycation (1) | Antihistaminic (2) | Antihyperglycemic (1) |
Antihypertensive (1) | Antihypertensives (1) | Antiinflamatory (1) |
Antimalarial (2) | Antimicrobial (5) | Antimicrobial activities (1) |
Antimicrobial activity (7) | Antimicrobial agent (1) | Antimicrobial efficacy (1) |
Antimicrobial Plants (1) | Antimicrobial resistance (3) | Antimicrobial resistance; Prescribing practice; Anti-infective agents; Antibacterials; Pharmacoepidemiology. (1) |
Antimicrobial Stewardship (1) | Antimicrobials (4) | Antimosquito (1) |
Antimycotic Activity (1) | antinociceptive (1) | Antioxidant (22) |
Antioxidant ; carotenoid ; humans ; half-life ; status ; absorption . (1) | Antioxidant activity (10) | antioxidant effect (1) |
Antioxidant properties (1) | Antioxidants (6) | Antiplatelet (1) |
Antiplatelet and anticoagulant therapy. (1) | Antipsychotics (2) | antipyretic (2) |
Antiretroviral drugs (1) | Antiretroviral therapy (2) | Antiretrovirals (1) |
Antispasmodic (1) | Antithrombotic (2) | Antithyroid drugs (1) |
Antitubercular (1) | Antitubercular activity (1) | Antitubercular drugs. (1) |
antiulcer (1) | Antiurolithiatic activity (3) | Antivenom (1) |
Antivenom reactions (1) | Antiviral (2) | antiviral activity (2) |
Antiviral RNA (1) | Anti– microbials (1) | Anxiety (5) |
Anxiety disorder (1) | Anxiolytics (1) | APAP (1) |
APC (1) | Aphthous stomatitis /ulcer (1) | Apoptosis (3) |
Application (1) | Application to PK profile studies (1) | applications (1) |
Appropriateness (1) | Aqueous extract (3) | AR Caps (1) |
Arabic gum (1) | ARBs (1) | ARDS (1) |
Area above the blood glucose levels-time curve. (1) | area of wound healing (1) | Areca nut (1) |
Arginase (2) | Arginine (1) | Aripiprazole (1) |
Armodafinil (1) | ART (1) | Artemia salina (1) |
Artemia salina. (1) | Artemisia (1) | Artemisia absinthium (1) |
Artemisia macrocephala (1) | arterial hypertension (1) | Arterial stiffness (2) |
Arteriovenous malformation (AVM) (1) | Arthralgia (2) | Arthritis (1) |
Artificial intelligence (1) | Artificial Neural Networks (1) | ARV Drugs (1) |
Ascorbic acid (3) | ASEAN (1) | Asenapine (1) |
asian developing nations (1) | Asiaticoside (1) | Asparagus racemosus (1) |
Asparagus racemosus root extract (1) | Aspergillus niger (2) | Aspergillus niger. (1) |
Aspergillus terreus (1) | Aspirin (2) | Assay (2) |
Assessment (1) | astasia (1) | Asthma (6) |
Asymptomatic neurocognitive impairment (1) | Ataxia (5) | ATC/DDD (3) |
Atenolol (1) | Atherosclerosis (1) | Atherosclerotic Vascular Disease (1) |
Athlete Biological Passport (1) | Atorvastatin (5) | Atorvastatin calcium (1) |
Atorvastatin. (1) | ATP synthase inhibitor (1) | ATP- sensitive K+channel (1) |
Atractylis flava Desf (1) | Atrial fibrillation (1) | Atropine (1) |
Attitude (9) | Attitude and practice (1) | Attitude. (1) |
Attitudes (2) | Attitudes and Practice in Health (1) | Atypical antipsychotics (1) |
Aubacute toxicity (1) | Aucubin (1) | Authors (1) |
Authorship issues (1) | Autism spectrum disorders (1) | Auto antibody (1) |
Auto medication (1) | Autodock Vina. (1) | Autoimmune disease (1) |
Autoimmune disorders (1) | Autoimmunity (1) | Averrhoa bilimbi (1) |
Avicel (1) | AWaRe Classification (1) | Awareness (7) |
Ayurveda (2) | Ayurvedic (1) | Azelaic acid (1) |
Azilsartan medoxomil (1) | B cell epitope (1) | Back pain (1) |
Bacoside A3 (1) | Bacteremia (1) | Bacteria (2) |
Bacterial contamination (1) | Bacterial isolates (2) | Bacteriological culture (1) |
Bacteriostatic (1) | Baker Venkataraman transformation (1) | Bamboo betung (1) |
Bambusa vulgaris (1) | Banana (1) | Bangladesh (3) |
bark (1) | Barleria cristata (1) | Barriers (1) |
Bauhinia purpurea (1) | Bauhinia racemosa (1) | Bauhinia variegata (2) |
Bay-K-8644 (1) | Bayesian confidence propagation neural network (1) | BCG vaccine (1) |
BCS-IV drug (1) | Beauty Salon Owner (1) | Beck Depression Inventory (1) |
Beck Depression Inventory(BDI) (1) | Bedaquiline (1) | Behavioral research (1) |
Behaviour (1) | Belief (2) | Benchmarking (1) |
Benzimidazole derivative (1) | benzimidazoles (2) | Benzodiazepines (1) |
Benzothiazole analogues (1) | Benzo[d]oxazole-2-thiol (1) | Berberis integerrima Bunge (1) |
Beta-lactamase (1) | Beta-lactamic (1) | Bibliographic characterstics (1) |
BIbliometric. (1) | Bibliometrics (18) | Bibliometrics. (3) |
BIBN4096 (1) | Bilayered floating tablets (1) | Bioactive compound (1) |
Bioactive Metabolites (2) | Bioactivity (1) | Bioadhesive (1) |
Bioanalytical (2) | Bioanalytical method (2) | Bioanalytical method development (1) |
Bioassay (1) | bioavailability (8) | Biodegradable (1) |
Bioethics (1) | Biofilm (1) | Biohazard (1) |
Biologics (1) | Biology (1) | Biomarker (2) |
Biomaterials (1) | Biomedical (1) | Bioprospecting. (1) |
Biopsy Proven Acute Rejection (1) | Biosafety (1) | Biosafety Engineering Control (1) |
Biosimilars (2) | Biotechnology (2) | Bipolar affective disorder drugs (1) |
Bisphosphonates (2) | Bitter (1) | Black Garlic (1) |
Black tea extract (1) | BLAST (1) | Bleaching (1) |
Bleeding time (1) | Bleomycin (1) | Blonanserin (1) |
Blood brain barrier (1) | Blood donor (1) | Blood glucose (1) |
Blood groups (1) | Blood pressure (4) | Blood safety (1) |
Blue and red from (1) | Body Mass Index (1) | Body Mass Index (BMI). (1) |
Boerhaavia Diffusa (1) | Bone (2) | Book Review (1) |
Borg scale (1) | botulinum toxin (1) | Box-Behnken (1) |
Bpharm (1) | Brahmi vati (1) | Brain (1) |
Brain targeting (2) | Braindisoders (1) | Brand Drugs (1) |
brand name drugs (1) | Branded drugs (1) | Branded medication (1) |
Branded medicine (1) | Bratton-Marshall reagent (1) | Brazil (1) |
Breast cancer (6) | Breast Feeding (1) | Breastfeeding (2) |
Brewer’s yeast (1) | Brief COPE scale (1) | Brief medication questionnaire (1) |
Brimonidine tartrate (1) | brine shrimp lethality bioassay (1) | Brine-shrimp lethality. (1) |
Broad spectrum antibiotics (1) | Brochures (1) | Bromelain (1) |
Bromeliaceae (1) | Bromocresol purple (1) | Bronchial Asthma (2) |
Bruxism and Dentistry (1) | Bryonia laciniosa (1) | Buccal (1) |
Buccal Patches (1) | budget forecasting (1) | Bufadienolide (1) |
Bullous eruption (1) | bungarotoxin (1) | Bungarus caeruleus (1) |
Bungur (1) | Buni-berry extract (1) | Buoyancy (1) |
Buoyant microspheres (1) | Burden Of Disease (1) | Burn wound (1) |
Business method (1) | Business model (1) | Butea monosperma (1) |
C-reactive protein (1) | C. albicans (1) | C60 derivatives (1) |
C934 (1) | CA125 (1) | Ca2+ channels (1) |
Cadmium chloride (1) | Caesalpinia decapetala (1) | Caesalpinia pulcherrima (1) |
Caesalpinia pulcherrima (L.) Sw. stem bark (1) | Caesalpinia sappan (1) | CAGR (1) |
Calcineurin inhibitor (1) | Calcium (2) | Calcium channel blocking (1) |
calcium channel blocking activity (1) | Calcium oxalate (1) | Calcium phosphate (1) |
Calcium silicate (1) | Calendula officinalis (1) | calendula oil (1) |
CAM Assay (1) | Camelia sinensis extract (1) | Camellia sinensis (1) |
Camptothecin (1) | Canagliflozin (1) | Cancer (7) |
Cancer Chemotherapy (2) | Cancer treatment (1) | Candida (2) |
Candida albicans (4) | Candida albicans. (1) | CaOx crystal aggregation (1) |
CaOx crystal nucleation (1) | CAP-e (1) | Capacity (1) |
Capsule (1) | capsules (1) | carbamazepin (1) |
Carbamazepine (4) | carbohydrazide (1) | Carbomyl Linkage (1) |
carbon tetrachloride (2) | carbonyl compounds (1) | Carbopol (1) |
Carbopol 940 (1) | Carcinogenic substances (1) | Carcinoma. (1) |
cardiac arrhythmias (1) | Cardiac care (1) | Cardiac complication (1) |
Cardiac remodeling (1) | Cardiology (2) | Cardiology. (1) |
Cardioprotection (1) | Cardioprotective (1) | Cardiotoxicity (2) |
Cardiovascular disease (2) | Cardiovascular drugs (1) | Cardiovascular Outcomes (1) |
Career Choices (1) | Carica papaya L. (1) | Carnaúba (1) |
Carnauba wax (1) | carrageenan (2) | Caryocar coriaceum (1) |
Case report (1) | Casein (1) | Casein Phosphopeptide-amorphous calcium Phosphate (1) |
Catalase (1) | catalepsy (2) | Cation-pi (1) |
CationicGuargum (1) | Caulerpa lentillifera (1) | Causality assessment (2) |
Causality scales (1) | CCKNOW - Crohn’s and Colitis Knowledge assessment questionnaire (1) | CCl4 (1) |
CD150 (1) | CD244.2 (1) | CD48 (1) |
Cefixime (1) | Cefotaxime (1) | ceftriaxone and co-amoxiclav (1) |
Cefuroxime (1) | Cefuroxime Axetil (1) | cell viability Glycyrrhiza glabra (1) |
Cellulase (1) | Cellulite (1) | Cellulitis (1) |
Cellulose (2) | Cemented (1) | Cementless (1) |
CEN (1) | Centella asiatica (3) | Central composite design (4) |
Central cord syndrome (1) | Central post-stroke pain (1) | Cephalexin (2) |
Ceramics (1) | Cerebellar ataxia (1) | Cerebellar atrophy (1) |
Cerebellar nuclei degeneration. (1) | Cerebrospinal Fluid. (1) | Cerebrovascular Accident (1) |
Cerebrovascular Disorder (1) | Cervical bulge (1) | Cervical dentine hypersensitivity (1) |
Cervical lymphadenopathy (1) | CFFF (1) | CGRP (1) |
chalcone (1) | chalcones (3) | Challenges (1) |
Chamomile tea (1) | Characterization (4) | Chebulinic acid (1) |
Chemical stability (1) | Chemiluminescence (1) | Chemomechanical removal (1) |
Chemometrics (3) | Chemotaxis (1) | Chemotherapy (7) |
Chewable tablets (1) | Chewing gum (1) | Child Care (1) |
Childhod (1) | Childhood cancer (1) | Children (4) |
Children and youth (1) | Children Dentistry (1) | Children. (2) |
Chitin (1) | Chitosan (8) | Chitosan Acetate. (1) |
chitosan microspheres (1) | Chitosan nanoparticle (1) | Chitosan-g-HPβCD (1) |
Chlamydomonas reinhardtii (1) | Chloramphenicol (1) | Chlorhexidine (2) |
Chlorohexidine (1) | cholesterol (1) | Cholesterol HDL (1) |
Cholinesterase inhibitors (1) | Chromatography (2) | Chromotropic acid reagent (1) |
Chronic disease (1) | Chronic Heart Failure (1) | Chronic hepatitis B (1) |
Chronic kidney disease (2) | Chronic Obstructive Pulmonary Disease (COPD) and Elderly Patient. (1) | Chronic Periodontitis (1) |
Chronic use (1) | Chrysophyllum cainito L. leaves (1) | Cicer arietinum (1) |
Cigarette smoke (1) | Cilostazol (1) | Cinnamaldehyde (1) |
Cinnamic acid derivatives (1) | Cinnamomum cassia (1) | Ciprofloxacin (2) |
Citronella (1) | Citrus hystrix (1) | Citrus limon (2) |
CKD (1) | CKMB. (1) | Claims (1) |
Clarithromycin (1) | Classification (1) | Clastogenicity (1) |
Cleistanthin A (3) | cleistanthin B (3) | Cleistanthus Collinus (2) |
Clinic Epidemiology (1) | Clinical attachment (1) | Clinical attachment level (1) |
Clinical efficacy (1) | Clinical equivalence (1) | Clinical manifestation (1) |
Clinical perspective (1) | Clinical Pharmacist (1) | Clinical pharmacist care (1) |
Clinical pharmacist intercession (1) | Clinical Pharmacists (1) | Clinical pharmacology (1) |
Clinical Pharmacy (1) | Clinical Pharmacy Services (1) | Clinical research (1) |
Clinical symptoms (1) | Clinical trial (1) | Clinical trials (1) |
Clinicians (1) | clonidine (2) | Clopidogrel (1) |
Clopidogrel bisulfate (1) | Closed melt (1) | Clove (1) |
cloxacillin (1) | Cluster analysis (1) | CME (1) |
CNC (1) | CNF (1) | CNS stimulants (1) |
Co-crystal (1) | Co-Formers (1) | Co-grinded mixture (1) |
Co-morbidities (1) | Co-Morbidity (1) | Co-morbidity. Correspondence (1) |
co-precipitation method (1) | Co-surfactant (1) | Cochlopermum tinctorium (1) |
coding system (1) | Cognition (2) | Cognitive impairment (1) |
Cogrinding (1) | Colloidal carriers (1) | Colloidal silicone dioxide (1) |
Colon targeted delivery (1) | Colon targeted drug delivery. (1) | Colon targeting (1) |
Colonic delivery (1) | Colonoscopy (1) | Colorectal cancer (1) |
colorimetric assay (1) | Column chromatography (1) | Combination tablet (1) |
Combination Therapy (1) | Combinatorial effect (1) | Comet assay (1) |
Common Carp (1) | common cold (1) | common cold and cough (1) |
Common warts (1) | Communicable Disease Control (1) | Community Pharmacies (2) |
Community pharmacist (3) | Community Pharmacists (2) | Community pharmacy (3) |
Community Pharmacy Patient Questionnaire (1) | Community Pharmacy Services (1) | Comorbid (1) |
Comorbidity (1) | Comparative dissolution (1) | comparative molecular similarity indices (1) |
comparative molecular Þ eld analysis (1) | Comparison (1) | compensation (1) |
Complementary and alternative medicine (2) | complementary and alternative medicines (1) | Complementary and alternative therapy (1) |
complete epithelization (1) | Complexation (1) | Compliance (1) |
Complications (1) | compound 48/80 (2) | compritol 888 ATO (1) |
Computer (1) | Computer literacy (1) | computer-aided instructions (1) |
Computer-aided learning (1) | Computerized screening systems (1) | Computing methods (1) |
CoMSIA (1) | Cone-beam tomography (1) | Conessine (1) |
Congenital infection. (1) | Conjugation (1) | Constipation (1) |
Consumer (1) | Consumer perception (1) | Consumer side effects reporting from (1) |
Consumer’s Perception (1) | Content validation (1) | content validity (1) |
continuing education (2) | Continuous Pharmacy Education. (1) | Contract research (1) |
Contract research organizations (1) | Control (1) | Controlled release (4) |
Convenience (1) | convolution (1) | convulsions (1) |
cooperative practice (1) | COPD (2) | Coprocessed excipient (1) |
Cordia obliqua (1) | Corneal bacterial ulcers (1) | Corneal opacities (1) |
Coronally advanced flap (1) | Coronavirus (1) | Coronavirus disease (1) |
Coronavirus disease 2019 (3) | Correlation (2) | Corticosteroid (2) |
Corticosteroids (2) | Cosmetic (2) | Cosmetic products (1) |
Cosmetics (1) | Cosmetics use-related adverse reactions (1) | Cosolvency (1) |
Cost analysis (1) | Cost avoidance (1) | Cost Minimization (1) |
Cost of illness (2) | Cost saving (1) | Cost-effectiveness analysis (1) |
Cost. (1) | Costing Analysis. (1) | Cotton dust (1) |
Cotton oil (1) | cotton pellet (1) | Cough (1) |
Cough medicine (1) | cough. (1) | Counterfeit Pharmaceutical Products (1) |
Counterfeiting (1) | COVID -19 (2) | COVID-19 (20) |
COVIID 19 (1) | CPs (1) | Cramer’s Matrix method (1) |
CRC (1) | Cream (1) | creatinine (1) |
Crinum asiaticum (1) | CRISPR/Cas9 (1) | Critical Care Unit (CCU) (1) |
Critical Material attributes (1) | Critical material attributes (CMAs) (1) | Critical Quality Attributes (1) |
Critical quality attributes (CQAs) (1) | Critical Thinking (1) | cromolyn sodium (1) |
Cronbach’s alpha (1) | Croscarmellose sodium (CCS) (1) | Crospovidone (1) |
Crospovidone (CP) (1) | Cross carmellose sodium (1) | cross-linking agents (1) |
Cross-sectional study (1) | Crossandra (1) | Croton zehntneri (2) |
Crystallinity (2) | CTCAE (2) | CTEPH (1) |
Cucumis metuliferus (1) | Cucumis sativus (1) | Culex quinquefasciatus (1) |
CUMIN. (1) | Cuminosides (1) | Curcuma longa (1) |
Curcumin (4) | current indian scenario of drug interactions (1) | Curriculum (1) |
curriculum development (1) | Cutaneous Adverse Drug Reactions (CADRs) (1) | Cutaneous manifestation (1) |
Cutaneous reaction (1) | CXCR4 (1) | Cyclodextrin (1) |
Cyclooxegenase-2 inhibitor (1) | Cyclooxygenase (2) | cyclophosphamide (1) |
Cymbopogon citratus (1) | Cynodon dactylon (2) | CYP genes ; South Indian population ; polymorphisms (1) |
Cyprinus carpio (1) | Cyst (1) | Cytochrome P 2C9 (1) |
Cytokine (1) | Cytosine (CYS) (1) | Cytotoxic (1) |
Cytotoxic activity. (1) | Cytotoxic agents (1) | Cytotoxicity (4) |
CZE (1) | D&C (1) | D-optimal design (1) |
Daily Defined Dose (1) | Dammam (1) | Dapsone (1) |
DASS-21 scale. (1) | Data mining algorithms (1) | DCA (1) |
DDD (1) | DDX3 (1) | Death Receptors (1) |
Decaschistia crotonifolia Wight and Arn. (1) | Decision making (1) | Deep vein thrombosis (1) |
deferasirox (1) | deferiprone (1) | Deficiency (1) |
Definitive screening design (DSD) (1) | Degenerative disc disease (1) | Degradation (1) |
Degradation studies (1) | Dehydrozingerone (1) | Delignification (1) |
Delirium (2) | Dementia (1) | democratic government (1) |
Dengue (1) | Dengue high fever (1) | Dental caries (5) |
Dental Caries. (1) | Dental decay (1) | Dental implants (2) |
dental management (1) | Dental Prosthesis (2) | Dental prosthesis. (1) |
Dental Restoration (1) | Dental Students (1) | Dentistry (3) |
dentistry. (1) | Dentists (1) | Denture Stomatitis (1) |
Deodorants (1) | Dependence (1) | Depigmentant (1) |
Depok Primary Health Care (1) | Deprescribing (1) | Depression (5) |
Depression 1 (1) | Dermatology (1) | Dermatology life Quality Index (1) |
Dermatology. (1) | Dermic implants (1) | Design of experiments (DoE) (1) |
Design of experiments. (1) | desirability function (1) | Desirability index. (1) |
Desmodium gangeticum (1) | Desolvation Method (1) | Detorsion (1) |
Deuterium (1) | Developmental regression (1) | device safety (1) |
dexamethasone (2) | Dexibuprofen (1) | Dextrin (1) |
DIA (1) | Diabetes (9) | diabetes and diabetic vascular complications (1) |
Diabetes mellitus (17) | diabetes mellitus, (1) | Diabetes Type-II (1) |
Diabetes, glucose (1) | Diabetes. (1) | Diabetic (1) |
diabetic dyslipidemia (1) | Diabetic nephropathy (1) | Diabetic retinopathy (1) |
Diabetic Wound (1) | Diacerein (1) | DiaKure (1) |
Diazepam (1) | diclofenac (2) | Diclofenac SLN (1) |
Diclofenac sodium (1) | Dicloxacillin sodium (1) | Dicots (1) |
Dicyclomine (1) | differential scanning calorimetry (1) | diffuse transmittance (1) |
Diffusion method (1) | Digital marketing (1) | Dillenia indica (2) |
Dilleniaceae (1) | Diltiazem Efficacy (1) | Diltiazem hydrochloride (2) |
Dimethylpyrimidin-derivatives (1) | Dip coating (1) | Diplotropis ferruginea (1) |
direct compression (3) | Direct to consumer advertising (1) | Directly observed treatment short-course (1) |
Directly observed treatment shortcourse (1) | Discharge against medical advice (DAMA) (1) | discharge orders (1) |
DISCLE (1) | Discrepancies (1) | Discriminant analysis (1) |
Disease (1) | Disease free survival (1) | disintegration (1) |
disintegration time (1) | Disproportionality Analysis (1) | Dissolution (5) |
dissolution enhancement (1) | Dissolution rate (1) | Diuretic (1) |
Diuretic activity (2) | Diuretics (1) | DMAIC (1) |
DMH (1) | DNA barcoding (1) | DNA damage (1) |
DNA fragmentation (1) | docking (7) | Docking studies (2) |
docking. (1) | Doctor (1) | Documentation (1) |
Documentation and records (1) | Donepezil hydrochloride (1) | Dopamine (1) |
Dosage formulation (2) | Dosage regimen (1) | Dose-dependent (1) |
Dossier. (1) | DOTS (1) | DOTS plus (1) |
Doxorubicin (2) | Doxorubicin; FRAP assay (1) | Doxycycline (1) |
DPP-IV (1) | DPPH Assay (1) | DPPH radical scavenging assay (1) |
DPPH scavenging (1) | DRcaps (1) | DREEM. (1) |
DRESS syndrome (1) | Dried blood spot. (1) | Dried blood spot; pharmacokinetic; validation; hydrochlorothiazide (1) |
droplet size (1) | Droplet-based Bioprinting (1) | Drug (2) |
Drug allergy tests (1) | Drug carriers (1) | Drug delivery (3) |
Drug delivery denture (1) | Drug Design (1) | Drug detailing (1) |
Drug Discovery (1) | drug disposal (2) | Drug drug interactions (1) |
Drug Hypersensitivity (2) | Drug induced nephrotoxicity (1) | Drug Information and Literature Evaluation (1) |
drug interaction (2) | Drug interaction (DI) (1) | drug interaction management (1) |
Drug Interaction probability scale (1) | drug interactions (3) | Drug Policies (1) |
Drug prescriptions (1) | Drug product (1) | Drug regimens (1) |
Drug Related Problems (4) | Drug related side effects (1) | drug release (1) |
Drug Resistance (2) | Drug risk ratio (1) | Drug safety (3) |
Drug Safety. (2) | Drug therapy (1) | Drug utilisation patterns (1) |
Drug utilization (3) | Drug utilization pattern (1) | Drug utilization review (1) |
drug utilization study (1) | Drug utilization. (1) | Drug-drug conjugate (1) |
drug-drug interactions (5) | Drug-related problem (2) | Drug-Related Side Effects and Adverse Reactions (1) |
Drug-SLS tablets. (1) | Drugedrug interaction (1) | Drugs (3) |
Drugs and Cosmetics rules (1) | Drugs of abuse (1) | drug–drug gliclazide (1) |
Drug–drug interaction (1) | Dry extract cinnamon (1) | Drying techniques (1) |
DSPC (1) | Dual approach. (1) | Dual control release (1) |
Dual Therapy (1) | dual-target-directed drugs (1) | Dunaliella salina (1) |
Dynamic (1) | Dyslipidemias (1) | Dysphagia (1) |
E learning (1) | E-Cigarettes (1) | E-learning (1) |
E-pharmacy websites (1) | e-prescribing (1) | E. coli (1) |
E.crispa (1) | Early childhood caries (1) | Early-Related Complications (1) |
Eastern province (2) | Ebanaceae (1) | EC50 values (1) |
Economic (1) | Economic burden (1) | Eczema (1) |
Edaravone (1) | Eddy’s hot plate method. (1) | edema (1) |
Edible flowers (1) | Editorial (24) | Education (3) |
Education material (1) | Educational excellence (1) | efavirenz (2) |
Effectiveness. (1) | Efficacy. (1) | EGCG (1) |
Egfr (1) | egg albumin microspheres (1) | Elderly (1) |
Elderly Patients (1) | Electrochemical (1) | electrolyte release (1) |
electrolytes (1) | Electron beam radiation (1) | Electronic prescribing (1) |
Electronic prescription (1) | Electroporation (1) | Elemental analysis. (1) |
Elevated plus maze (2) | elevated plus maze model (1) | Elevated plus-maze (1) |
Elisa (1) | Ellman’s assay (1) | Emblica offi cinalis (1) |
Emergency contraception (1) | Emodin (1) | Emotional (1) |
Emotional domain (1) | Emulgel (2) | Emulsification and Solvent Evaporation (1) |
emulsion solvent diffusion method (1) | emulsion solvent diffusion-evaporation technique (1) | Encapsulation (2) |
Encholirium spectabile (1) | Endocrine disruptor (1) | Endogenous insulin (1) |
Endophytes (1) | Endothelial cells (1) | endothelial Nitric Oxide Synthase (1) |
Endothelial progenitor cells (1) | Endothelium (1) | Endothelium. (1) |
Enhanced patient care (1) | Enicostemma littorale (1) | Entire plant (1) |
Entrapment afficiency (1) | entrapment efficiency (2) | Envenoming (1) |
Environmental domain (1) | Environmental Factors (1) | Environmental factors. (1) |
Environmental Sciences (1) | Enzymatic hydrolysis (1) | Enzyme kinetics (1) |
eosinophil (1) | EPDS scale (1) | Epicatechin (1) |
Epidemic (1) | Epigallocatechin (1) | Epigallocatechin Gallate (2) |
Epigallocatechin gallate (EGCG) (1) | Epigenetics (1) | epilepsy (6) |
Epithelial ovarian cancer (1) | Epithelization (1) | EQ-5D-5L (1) |
EQ5D (1) | ER Matrix (1) | erbal drugs (1) |
erice declaration (1) | Erythema (1) | Erythema multiforme (1) |
Erythrina indica (1) | Erythrina variegata (1) | Erythrocyte sedimentation rate (1) |
Erythroderma (1) | erythropoietin (2) | Escherichia coli (1) |
Escitalopram oxalate (1) | ESI (1) | esomeprazole (1) |
Essential drugs (1) | Essential hypertension (2) | Essential medicine (1) |
essential medicines (2) | essential oil (5) | essential oil composition (1) |
Essential principles (1) | Esthetics Dental (1) | Estimated Glomerular Filtration Rate (1) |
Estrogen receptor alpha (1) | Ethambutol (1) | Ethanol (1) |
Ethanol extract (1) | ethanolic extracts (1) | Ethiopia (2) |
ethnicity (2) | Ethnomedicine (2) | Ethnopharmacy (1) |
Ethosomes (1) | Ethyl - 4- acetamido phenoxy acetate (1) | Ethyl acetate (1) |
Ethyl acetate fraction (1) | ethyl cellulose (2) | ethylcellulose (3) |
ethylene glycol (2) | Etiology (1) | Eucalyptus (1) |
Eucalyptus hybrid (1) | Eucalyptus oil (3) | eudragit (2) |
Eudragit RL 100 (1) | eudragit S100 (2) | Eudragit-L100 (1) |
Eudragit® S100 (1) | Eugenol (1) | Euphorbia hirta leaves (1) |
Eurycoma Longifolia Jack (1) | Evaluation (1) | EVD (1) |
Ex vivo tissue entrapment (1) | ex-vivo performance (1) | Ex-vivo permeation (1) |
Ex-vivo study (1) | Exacerbation (1) | Excess Alcohol Consumption (1) |
Excision wound model (1) | Expectoration (1) | Experience (1) |
experiences (1) | Experiential learning (1) | Experimental ischemic stroke (1) |
experimental study (1) | Expired medicines (1) | Expiry drugs (1) |
Exports (1) | Expression profile (1) | Extract (1) |
Extrapyramidal side-effects (1) | extrinsic stains (1) | extrusion (1) |
Extrusion-Based Bioprinting (1) | Eye lens (1) | Ezetimibe (2) |
Fabaceae (2) | Facial implants (1) | Facial Pain (1) |
Factor analysis (1) | factorial design (5) | Factors (1) |
Factors associated with medication non-adherence (1) | Falcipain-2 (1) | Fall-risk increasing drugs (1) |
Falls (1) | Family Planning Services (1) | Family satisfaction (1) |
family therapy (1) | famotidine (2) | fast disintegrating tablet (1) |
Fast Disintegrating Tablets. (1) | Fast dissolving film (1) | Fast dissolving films (1) |
Fast dissolving tablets (1) | Fasting serum insulin level (1) | Fat (1) |
Fatty acid profile (1) | FC reagent (1) | FDA AERS Database (1) |
FDA Approval (1) | Fenugreek (1) | Ferric reducing antioxidant power assay (1) |
Ferritin (1) | Ferrous sulfate (1) | Fetal Case Report (1) |
Fever (1) | Fialuridine', (1) | Ficus bengalensis (1) |
Ficus bengalensis (Moraceae) (1) | Ficus deltoidea (1) | Ficus racemosa (1) |
film (1) | film hydration (1) | Fine needle aspiration cytology (1) |
First permanent molars (1) | Fixed drug eruption (1) | Flavone (1) |
Flavonoid (3) | Flavonoid Compounds (1) | Flavonoid fraction (1) |
flavonoids (3) | Flavoxate HCl (1) | FlK-1 (1) |
Floating beads (1) | floating controlled drug-delivery system (1) | Floating Drug Delivery (1) |
Floating drug delivery system (1) | floating lag time (1) | Floating tablets (1) |
Floriculture (1) | Flow cytometry (1) | Flue (1) |
fluoroquinoes (1) | Fluoroquinolones (1) | Fluoxetine (1) |
Flupritine maleate (1) | flurbiprofen (1) | Flux (2) |
FMCG (1) | folkloric use (1) | Follow up treatment (1) |
Food drug and cosmetic act (1) | Forced degradation (4) | Forced degradation studies (1) |
forced swim test (1) | Formication (1) | Formulary (1) |
Formulary. (1) | Formulation (6) | Formulation and development (1) |
Formulation Development. (1) | Fortification (1) | Fortified antibiotics (1) |
Fourier transform infra red spectroscopic (1) | FPG (1) | FPGEE (1) |
Fraction (1) | Franz Diffusion Cell (3) | FrEA5 (1) |
free radical scavenger (1) | Free radicals. (1) | Freeze-drying (1) |
Freund’s complete adjuvant (1) | Fructo-Oligosaccharide (FOS) (1) | Frusemide (1) |
Frusemide-induced complications (1) | FTIR (5) | Full coverage occlusal plaques (1) |
Fullerenes (1) | Fumes (1) | functions (1) |
Fungal infections (1) | furosemide (1) | Future Health Care Professionals (1) |
Future healthcare professionals (1) | Future plans (1) | G6PD deficiency (1) |
GABA (2) | Gabapentin (1) | Galacto-Oligosaccharide (GOS) (1) |
Galic Acid (1) | gallic acid (3) | Galphimia glauca Clav (1) |
Gamma irradiation (1) | Gamma scintigraphy (1) | Gangrenous (1) |
Ganoderma lucidum (1) | Gap Junctions; Hypersynchronization; Pentylenetetrazole; Maximal Electroshock (1) | Garcinia daedalanthera extract (1) |
Garcinia imberti (1) | Garcinia imberti bourd (1) | Garcinia indica (1) |
Garcinia latissima (1) | gaseous contact (1) | gastric treatment (1) |
Gastric ulcer (1) | Gastro-retentive drug delivery system (1) | gastroprotection (2) |
gastroretentive (1) | gastroretentive drug delivery system (1) | Gatot Soebroto hospital. (1) |
GC-MS (1) | GC-MS analysis (2) | GC-MS. (1) |
GDP (1) | Gelatin (1) | Gelling Capacity. (1) |
Gels (1) | Gemcitabine HCl (GCH) (1) | gemfibrozil (1) |
Gender (1) | Gender and HIV. (1) | Gene expression (1) |
Gene expressions (1) | Gene modification (1) | Gene silencing (1) |
General medicine (1) | Generic (2) | generic drugs (4) |
Generic Medicine (2) | Generic medicines (2) | Generic name. (1) |
Generic substitution (1) | Generics (1) | Genetic polymorphisms (1) |
genetic Signature (1) | Genotoxin (1) | Genotype frequency (1) |
Gentamicin (6) | gentamicin sulfate (2) | Geriatrics (3) |
Gewald’s reaction (1) | GFAP (1) | Gibb’s reagent (1) |
Gina criteria (1) | Ginger (1) | Gingival hyperplasia (1) |
Gingival hypertrophy (1) | gingival pocket (1) | Gingival recession (1) |
Gingival thickness (1) | Gladiolus segetum (1) | glibenclamide (5) |
gliclazide (2) | Glidescore (1) | Glimepiride (2) |
glimepride (1) | Glipizide (3) | glitazars (1) |
Global (1) | Global education (1) | Global Papers (1) |
Global publications (7) | Glomerulonephritis (1) | Glucagon (1) |
Glucocorticoids (1) | Glucosamine (1) | Glucosamine sulphate (1) |
Glucose (1) | Glucose metabolism (1) | glucose tolerance test (1) |
glutathione (1) | Glycemic Control (1) | Glycerin (1) |
Glycerine (1) | Glyceryl monostearate (1) | Glycine max (1) |
Glycosylated hemoglobin (HbA1c) (1) | Glycosylated hemoglobin A1c (1) | Gnetum gnemon (2) |
Goal orientation (1) | Goldenhar syndrome (1) | good manufacturing practices (1) |
Google docs (1) | Gotu kola leaves extract (1) | Government sector (1) |
GPx (1) | Graft Rejection (1) | Graft Survival (1) |
Grafting (1) | Grafts (1) | Gram negative (1) |
Gram negative bacteria (1) | Gram positive (1) | Gram positive bacteria (1) |
Gram-Negative Organisms (1) | Gram-Positive Organisms (1) | Granulomatous Vasculitis (1) |
Grape seed extract (1) | Grape seed oil (1) | Grapes seed extract (1) |
Gravimetry (1) | Grazing angle X-ray diffraction (1) | Green tea (1) |
Green Tea Leaves Extract (2) | Grip strengthening test (1) | Griseofulvin (1) |
GSH (2) | Guanidine Moiety (1) | guanyl cyclase stimulator (1) |
Guest Editorial (1) | Guidelines (1) | Guinea pig (1) |
Gulf cooperation council (1) | Gum and fat fractions (1) | Gum arab (1) |
Gymnema Sylvestre (2) | Gynura procumbens (1) | Gypsum (1) |
GYTS (1) | H+ (1) | H-460 (1) |
H2 Receptor Antagonist (1) | H2O2 (1) | HAART (1) |
Habits (2) | Haematological (1) | Haematuria (1) |
Haemoglobin (1) | Haemolysis (1) | Haemolytic ratio. (1) |
Hair dye. (1) | Hair Growth Activity (1) | Hair Tonic (1) |
Hajj (1) | haloperidol (2) | Hand and Foot Syndrome (1) |
hardness (1) | Haritaki (1) | harmacotherapy-based problems (1) |
Harmonization (2) | Hartwigs Severity Assesment Scale (1) | Haryana (1) |
Hazardous drugs (1) | HbA1C (2) | HBV (1) |
HCT: Hydrocholrothiazide. (1) | HDAC4 (1) | HDAC7 (1) |
head twitch (1) | Health benefits (1) | Health Care Coordination and Monitoring (1) |
Health Care Costs (1) | Health care profession (1) | health care professionals (1) |
health care students (2) | Health care. (1) | Health Education (1) |
Health Expenditures (1) | Health for All (1) | Health Hazard (1) |
Health informatics (1) | Health Information Technology (1) | Health Knowledge (1) |
Health problems (1) | Health Professionals (1) | Health Professions Students (1) |
Health related quality of life (2) | Health risks (1) | Health Services Accessibility (1) |
Health Status Indicators (1) | Health Surveillance (1) | Healthcare (5) |
healthcare communication (1) | Healthcare Delivery (1) | healthcare expenditure (1) |
Healthcare Professionals (1) | healthcare providers (1) | Healthy volunteers (1) |
heart failure (4) | Heart failure clinics (1) | Heart Failure Hospitalization (1) |
Heat-shock (1) | Hematological parameters (1) | hematological toxicity (1) |
Hematology (2) | Hematoma (1) | Hematopoietic progenitors (1) |
Hemodialysis (2) | Hemoglobin (1) | Heparin (1) |
hepatic impairment (2) | Hepatic marker (1) | Hepatitis (1) |
Hepatitis B (1) | Hepatitis B virus core protein (1) | Hepatocellular (1) |
Hepatocurative (1) | hepatoprotective (4) | hepatoprotective activity (3) |
Hepatotoxicity (1) | HER1 (1) | HER2 (1) |
HER3 (1) | HER4 (1) | Herbal active ingredients (1) |
Herbal drugs (1) | Herbal formula (1) | Herbal medications (1) |
Herbal medications. (1) | Herbal medicine (2) | herbal medicines (1) |
Herbal therapy (1) | Herbaldb (1) | HET-CAM (1) |
Heterocyclic compound (1) | Heterotopic Pregnancy (1) | Hex (1) |
Hexane (1) | Hibiscus cannabinus Linn. (1) | Hibiscus rosa. (1) |
Hidradenitis suppurativa (1) | High fat diet (2) | High Fat Diet Model (1) |
High impact resin (1) | high performance liquid chromatography (1) | high performance thin layer chromatography (1) |
High-Cited Papers (3) | High-Cited Publications (1) | High-density lipoprotein cholesterol (1) |
High-fat diet (1) | high-performance liquid chromatography (2) | High-throughput screening (1) |
Higher education (1) | highly active antiretroviral therapy (1) | Highly Cited Papers (1) |
Himatanthus drasticus (1) | Hip Arthroplasty (1) | Hirsutism (2) |
Histocompatibility. (1) | Histological studies. (1) | Histopathological studies (1) |
Histopathology (3) | HIV (3) | HIV associated dementia. (1) |
HIV-1 RT (1) | HIV-associated neurocognitive disorder (1) | HIV/AIDS Patients (1) |
HL-60 and K-562 (1) | HLA (1) | HMG-CoA Reductase (1) |
Homalium zeylaicum (1) | Homeopathic medicines (1) | Homeopathy (1) |
homology modeling (1) | Honey (1) | Honeycomb (1) |
Hordeum vulgare (1) | Hordeum vulgare hull (1) | Horticulture (1) |
Hospital pharmacy (2) | Hospital Services (1) | hospitalized children (1) |
hospitalized patients (1) | Hospitals (1) | host (1) |
Host-guest interactions (1) | hot plate (1) | HP-ß Cyclodextrin complexes (1) |
HPLC (9) | HPLC (High Performance Liquid Chromatography) Ornidazole (1) | HPLC method validation (1) |
HPLC. (1) | HPMC (1) | HPMC capsules (1) |
HPMC K100M (2) | HPMC K4M (1) | HPTLC (7) |
HPTLC Fingerprinting (1) | HQLQ (1) | HRQoL (3) |
HSV-1 (1) | Human breast cancer cells (1) | Human breast cancer MCF -7 cells (1) |
human immunodeficiency virus (3) | human immunodeÞ ciency virus (1) | Human Papillomavirus (1) |
Human plasma (2) | human plasma level (1) | Human plasma; Liquid chromatography–tandem mass spectrometry (LC–MS/MS); Method validation; Pharmacokinetics (1) |
Humanitarian device exemption. (1) | Humours (1) | Hyaluronic acid (1) |
Hydnocarpus Pentandra (1) | Hydralazine hydrochloride (1) | Hydroalcoholic (1) |
hydrochlorothiazide (2) | Hydrochlorthiazide (1) | hydrogel (2) |
Hydrogels (1) | hydrogen sulfide (1) | hydrogenated castor oil (1) |
Hydrophilic drugs (1) | Hydrophillic sealants (1) | Hydrophobic sealants (1) |
Hydrotrophy (1) | hydroxy propyl methyl cellulose (1) | Hydroxyapatite (1) |
Hydroxyl radical (1) | Hydroxyproline (1) | hydroxypropyl cellulose (1) |
hydroxypropyl methyl cellulose (2) | Hydroxypropyl methylcellulose (2) | Hydroxypropyl methylcellulose E15 (1) |
Hydroxypropyl-β- cyclodextrin (1) | Hydroxypropylmethyl cellulose (1) | Hydroxypropylmethylcellulose (1) |
Hyperactive orofacial musculature (1) | Hypercholesterolemia (1) | Hypercholestremia (1) |
Hyperglycemia (1) | Hyperglycemic (3) | Hyperglycemic mice (1) |
Hyperhomocystienemia (1) | Hyperlipoprotienemia(a) (1) | hyperoxaluria (1) |
Hypersensitivity (1) | Hypersensitivity reaction (2) | hypertension (11) |
Hypertension( HTN) (1) | Hypertensive’s (1) | Hyperthyroidism (1) |
hypertriglyceridemia (2) | Hypertrophy (1) | Hyperzincuria (1) |
Hyphenated system (1) | hypoglycemic (1) | Hypoglycemic activity (1) |
hypolipidemic (1) | Hypomineralization (1) | Hypothyroidism (1) |
Hypozincaemia (1) | Iatrogenic dermatological reaction (1) | IBD (1) |
IBD - Inflammatory Bowel Disease (1) | IBS (1) | IC50 (2) |
ICH (2) | ICH guidelines (3) | ICP22 (US1) gene (1) |
Idiopathic Thrombocytopenia (1) | IL-17 (1) | IL-1β (1) |
IL-6 (2) | IL-MAE (2) | Illicit Drugs (1) |
Illiterate (1) | Iloperidone (1) | image analysis (1) |
imidazole (1) | Immediate release layer and Bioavailability (1) | Immune response (1) |
Immune suppression (1) | Immune system (1) | immunocytochemistry (1) |
Immunoinformatics (1) | Immunological response (1) | Immunomodulatory (2) |
Immunomodulatory effect (1) | Immunomodulatory model (1) | Impact (1) |
Impacted (1) | Improving (1) | Impurity (1) |
Impurity related substances (1) | In silico (2) | In silico docking (1) |
in situ gelation (1) | in vitro (4) | In vitro kinetics (1) |
In vitro penetration lotion (1) | In vitro penetration test (1) | In vitro Penetration Test. (1) |
In vitro release (1) | In vitro–In vivo (1) | in vivo (1) |
In vivo kinetics (1) | In-patien (1) | In-situ gel (1) |
in-vitro dissolution study (1) | In-vitro skin permeation (1) | Inappropriateness (1) |
Inclusion complex (1) | Inclusion Complexation (1) | inclusion complexes (2) |
indexed cost (1) | India (11) | India. (2) |
Indian context (1) | Indian publications (2) | Indian Traditional medicine (1) |
India’s publications (1) | Indigenous (1) | Indion 234 (2) |
Indion resin (1) | indomethacin (2) | Indonesia (3) |
Indonesian Herbal Database. (1) | Indonesian National Health Insurance (1) | Industry (2) |
Inequality (1) | infarct size (1) | Infection prevention (1) |
infective endocarditis (1) | infertility (1) | Infit and outfit indices (1) |
inflammation (4) | inflammatory bowel disease (2) | Inflammatory markers. (1) |
Inflorescence (2) | Information need (1) | Information system (1) |
Information Technology Officers (1) | Information tool (1) | Inhibitor MDM2 (1) |
Inhibitory activity (1) | Injectable (1) | innovation ecosystems (1) |
inorganic salts. (1) | Inquiry learning (1) | INR (1) |
inß ammation (2) | inß ammatory bowel diseases (1) | Insilico anticancer screening (1) |
insulin (6) | Insulin receptor (1) | Insulin regimen (1) |
insulin resistance (1) | Insulin resistance. (1) | insulin use in primary care (1) |
Insulinophobia (1) | Integrase inhibitor (1) | Integrated Courses (1) |
integrated economic analysis (1) | Intellectual Property l (1) | Intellectual property rights (1) |
intelligent tutoring (1) | Intensive care unit (1) | Intensive Care Unit (ICU) (1) |
Intensive Monitoring (1) | interaction (2) | interferon (1) |
interleukins (1) | International Collaboration (1) | International HIV dementia scale (IHDS) (1) |
international organization (1) | international organizations (1) | international trade (1) |
Internet (1) | Internet pharmacy (1) | Interocclusal device (1) |
interpretation (1) | Interventional tool (1) | Interventions (1) |
Intervertebral disc C4/5 and C5/6 (1) | Interview (1) | Intoxications (1) |
Intracanal medicament (1) | Intranasal delivery (1) | Intranasal Microemulsion (1) |
intraocular presuure (1) | Intrauterine Pregnancy (1) | Intravenous (1) |
Intravenous immunoglobulin (1) | Intrinsic and Extrinsic factors (1) | Invasive fungal infection (1) |
inventory index (1) | inventory management (3) | Investigation (1) |
investigators (1) | Invited Article (2) | Ion Gelation Method (1) |
ion pair complex (1) | Ionic gelation (1) | Ionic liquid (3) |
Ionic liquid- based microwave-assisted extraction (1) | ionic liquid-based microwave-assisted extraction (1) | Ionizing radiation (1) |
ionotropic gelation (1) | iontophoresis (2) | Ipsilateral symptoms (1) |
Iraq (1) | Iridoid glycoside (1) | iron chelation therapy (1) |
Irrational (1) | Irrigation (1) | Irvingia gabonensis (1) |
isatin (3) | ischemia (1) | ischemia-reperfusion injury (1) |
Ischemic (1) | ischemic heart disease (1) | ISO (1) |
Isolated aortic rings (1) | isoniazid (3) | isonicotinohydrazide (1) |
Isoprinosine (2) | Isopropyl myristate (1) | isoproterenol (1) |
isoxazoline (1) | itopride HCl (1) | IV Admixture (1) |
Jan-Aushadi (1) | JNC 8 Guidelines. (1) | Journal (1) |
Jurkat (1) | K+-ATPase β subunit (1) | K+ATP channel (1) |
K-CAPS (1) | K562 (1) | Kaffir lime (1) |
Kaifyat (1) | Kajjali (1) | Kakoli (1) |
Kalanchoe Pinnata (1) | Kantakari (1) | KAP (3) |
KAP Questionnaire (1) | KAP study (1) | Kappa Concordant value (1) |
Kappa. (1) | Karachi (2) | Kathakakhadiradi kashyam (1) |
Kati chakrasana (1) | Kawasaki disease (1) | Kernel powder (1) |
Ketamine (1) | Ketoacidosis. (1) | Ketoprofen (1) |
Ketorolac (1) | Ketorolac salt (1) | Key words: 5-FU (1) |
Key words: COVID-19 (1) | Key words: Esomeprazole (1) | kidney (2) |
Kidney stones (1) | Kidney Transplantation (1) | kinetic drug release (1) |
Kinetic Modelling (1) | KMnO4 (1) | Kneading (1) |
kneading method (1) | kneading technique (1) | knowledge (22) |
Kojic acid (1) | Kumar’s score (1) | Kushta (1) |
Kushta Gaodanti (1) | L-arginine (1) | L-Thyroxine (1) |
L. acidophilus (1) | labeling (1) | Laboratory findings. (1) |
Lacosamide (1) | Lactate dehydrogenase (1) | Lactobacilli (2) |
Lactobacillus (1) | Lag period (1) | Lagenaria siceraria (1) |
Lantana camara (1) | Lantana montevidensis (1) | Larvacidal (1) |
Larvicidal (1) | Laurence-Moon-Bardet-Biedl Syndrome (1) | Lawsone methyl ether (1) |
LC-MS (1) | LC-MS/MS (1) | LC/MS/MS (1) |
LC50 (1) | LCMS/MS (2) | LC–MS/MS (1) |
LDL-C (1) | Lead monoxide (1) | Leaf (1) |
Learning (1) | Learning process (1) | leaves (4) |
Left renal artery stenosis (1) | Leftover medicines, (1) | Leg Length (1) |
Leptin (1) | Letter to Editor (4) | Letter to the Editor (3) |
Letters to the Editor (6) | Leucaena leucocephala (1) | Leucas lavandulaefolia (1) |
Levocetirizine (2) | Levodopa (1) | Levofloxacin (1) |
Lexicomp (1) | Lichen planus (1) | Licofelone (1) |
Ligand-based drug design (1) | Light and dark model (1) | Lightening (1) |
Limb Length (1) | Limbs (1) | lime fruit (1) |
Linagliptin (1) | Lindernia ciliata (1) | Linezolid (1) |
Linoleic acid (1) | lipid matrix (1) | lipid metabolism (2) |
Lipid Microparticles (1) | lipid microspheres (1) | Lipid nanocrystals (1) |
Lipid peroxidation (3) | Lipid peroxidation. (1) | lipid peroxides (1) |
lipid profile (1) | Lipid profile membrane bound enzymes (1) | lipids (1) |
Lipinski rule. (1) | lipoic acid (1) | liposome (1) |
Lippia (1) | Liquid chromatography (1) | Litharge (1) |
Lithium (1) | lithium toxicity (1) | Live-well™ (1) |
liver function (2) | Liver necrosis (1) | Liver tonic (1) |
Liver Transplantation (1) | Local drug delivery (1) | Lockdown (1) |
locomotor activity (1) | Long term memory (1) | Low-density lipoprotein cholesterol (1) |
Lozenges (1) | LRTIs (1) | Luffa echinata (1) |
Lumbar Spinal Stenosis (1) | Luminesce (1) | Lung (1) |
Lung cancer (3) | Lupenoic acid (1) | Lupus (1) |
Lycatab C (1) | Lympadenopathy (1) | lymphadenitis (1) |
Lymphocyte (1) | Lymphoma (1) | Lysozyme (1) |
M. tuberculosis H37Rv (1) | MABA method (1) | Maceration (1) |
Macromicroscopy study (1) | Macrophage (1) | Macrophage cell line (1) |
Mahkoside A (1) | Major Contributed Organizations (1) | Malaysia (5) |
Malaysia. (1) | Malaysian. (1) | Male (1) |
Male fertility (1) | Maleic Acid (1) | Malignant lesions (1) |
Malignant transformation (1) | Malocclusion (2) | malondialdehyde (2) |
Maltodextrin (2) | Mammary carcinoma (1) | Mandibular hypoplasia (1) |
Mangiferin (1) | Mangosteen Peels (1) | manidipine dihydrochloride (1) |
Mannich base (1) | Mannich Bases (1) | Marine fungi compounds (1) |
Marketed Brands (1) | Mast cell (1) | Maternal Care. (1) |
Mathematical modeling (1) | matrix (1) | Matrix Tablet (1) |
matrix tablets (3) | Maxillofacial complications (1) | MCF-7 (1) |
MD simulation (1) | MDA (2) | MDR-TB (2) |
mean age (1) | Mechanism (1) | mechanisms (1) |
Meclizine HCl (1) | Medical (1) | Medical and non-medical (1) |
medical costs (1) | Medical device (1) | Medical device recalls (1) |
medical errors (1) | Medical informatics (1) | Medical Inpatients (1) |
Medical practitioner (1) | Medical Representative (1) | Medical Respresntative (1) |
Medical sales representative (1) | Medical students (2) | medication adherence (6) |
medication adherence behaviour (1) | medication error (2) | Medication errors (2) |
Medication non-adherence (1) | Medication reconciliation (1) | Medication regimen complexity (1) |
Medication related problems. (1) | medication safety (2) | Medication taking (1) |
Medication taking behaviour. (1) | Medication understanding (1) | medication-/drug-related problem (MRP/DRP) (1) |
Medications (1) | Medicinal ornamental plants (1) | Medicinal plant (1) |
Medicinal plants (4) | Medicine (2) | Medicine consumers (1) |
Medicine disposal (1) | medicine-use practices (1) | Medicines storage (1) |
Medicines wastage (1) | Mediterranean diet (1) | Megakaryocytes (1) |
Melanesia (1) | Melastoma malabathricum (1) | Melinjo (2) |
Meloxicam (1) | Memory (2) | Memory and learning. (1) |
Men (1) | Men who have Sex with Men (1) | Men who have Sex with Men. (1) |
Menaquinone-4 (1) | Menstrual cycle (1) | Mental Disorders (1) |
Mental health (4) | Mental health challenges (1) | Mental health education (1) |
Mental health services. (1) | Mentha arvensis (1) | Menthol oil (1) |
mesalamine (1) | Metabolic ratio (1) | Metabolic syndrome (1) |
Metabolism (1) | Metabolite profiling (2) | Metabomics (1) |
metagenomic (1) | metformin (9) | metformin hydrochloride (1) |
Methanol (1) | methanolic extract (1) | methocel (2) |
method development (5) | method development. (1) | Method optimization (1) |
method validation (5) | Method validation Valsartan (1) | Methotrexate (1) |
methyl orange (1) | methyl-b cyclodextrin (1) | metoprolol tartarate (1) |
MetS (1) | Mevalonate (1) | MHCs (1) |
Mice. (1) | Micelle (1) | Micro emulsion (2) |
Micro particles. (1) | Micro-emulsion (1) | microbial contamination (1) |
Microbiological (1) | Microbroth dilution (1) | Microcapsules (1) |
microcrystalline cellulose (5) | microdilution (1) | Microdosing (1) |
Microemulsion (1) | Microencapsules (1) | Microenvironment. (1) |
microneedles (1) | Micronucleus assay (1) | microparticles (1) |
MicroRNA (1) | microsphere (1) | Microsphere Phytosome (1) |
microspheres (6) | microtriches (1) | Microwave assisted extraction (1) |
Microwave-Assisted Extraction (2) | miglitol (1) | Migraine (3) |
migraine management, (1) | Migrant labor (1) | Mild neurocognitive disorder (1) |
Milk (1) | Milnacipran (1) | Mimosa pudica (1) |
Mineral trioxide aggregate (1) | minimal inhibitory dose (1) | Minimum Inhibitory Concentration (MIC) (1) |
mismatches (1) | mitochondria (1) | Mix mode (1) |
MLR (1) | MMAS-8 - Modified Morisky Adherence Scale-8 (1) | Modafinil (1) |
Modeling (1) | modern medicine (1) | modified melt dispersion technique (1) |
Modified Starches (1) | MODY (1) | Mol inspiration (1) |
Molar Incisor (1) | Molecular characterization (1) | Molecular docking (10) |
molecular docking and anti cancer activity. (1) | Molecular Docking. (1) | Molecular Dynamic (1) |
Molecular dynamics (3) | Molecular Dynamics Simulations (1) | Molecular Imprinted Polymer (1) |
Molecular mimicry (1) | Molegro Virtual Docker 6.0 (1) | Molinspiration. (1) |
Momordica charantia (1) | Momordicin II Natural Products (1) | monoamine oxidase B (1) |
Monocots (1) | Monophyletic (1) | montelukast (2) |
montelukast sodium (1) | Montelukast, (1) | Mood stabilizers (1) |
moraceae (1) | Morbidity (1) | Morin and validation (1) |
Moringa (1) | Moringa oleifera (3) | Moringa oleifera. (1) |
Morisky medication adherence questionnaire (1) | Morocco (3) | Mortality (4) |
Morus alba (2) | Mosquito repellent (1) | Mouth Dissolving Tablets (1) |
mouth-dissolving film, (1) | Mpharm (1) | MPO activity (1) |
MPTP (1) | MRI Contrast agents (1) | MTT Assay (2) |
MTT assay. (1) | MTT method (1) | MUC2 (1) |
MUC6 (1) | Mucoadhesive (1) | Mucoadhesive agent (1) |
mucoadhesive formulation (1) | Mucoadhesive Oral In situ gel (1) | mucoadhesives (1) |
mucodhesive (1) | Mucormycosis (2) | Mulberry (1) |
multi granules (1) | Multi Organ Failure (1) | Multidrug Resistant (1) |
multidrug resistant pathogens (1) | Multidrug-resistant bacteria (1) | Multikinase Inhibitor (1) |
multiparticulates (1) | multiparticulates dosage form (1) | Multiple myeloma (1) |
Multiple Organ Dysfunction Syndromes (MODS) (1) | Multiple Organ Failure (1) | multiple regression (1) |
multiple regression analysis (1) | Multisystem inflammatory syndrome-children (1) | Multitargeted drug (1) |
Murdarsang (1) | Murraya koenigii L.Sprengel S.mutans (1) | Muscle tmd (1) |
Mycobacterium tuberculosis. (1) | Mycophenolate mofetil (2) | Mycophenolic acid (1) |
Myelin pallor (1) | Myeloperoxidase (1) | myocardial infarction (2) |
Myomectomy. (1) | Myrica esculenta (1) | Myristicin (1) |
Myrobalan (1) | N-aminoimidazoles (1) | N-napthyl ethylene diamine dihydrochloride (1) |
Na+/K+-Atpase (1) | NABP (1) | NACO. (1) |
Nadi shuddhi pranayama (1) | Naftopidil (1) | Naltrexone (1) |
nano size (1) | Nanocarriers (1) | Nanocellulose (1) |
Nanocrystals (1) | Nanoemulsion (1) | Nanofibers (1) |
Nanoformulation (2) | nanoformulations (1) | Nanonization. (1) |
Nanopacticle (1) | Nanoparticle (3) | Nanoparticles (12) |
Nanosuspension (1) | Nanosuspension tablets (1) | Nanosuspensions (1) |
Naphthoquinone derivative (1) | NAPLEX (1) | naproxen (1) |
Naranjo (1) | Naranjo algorithm (2) | Naranjo algorithm. (1) |
Naranjo Causality Assessment (1) | Naranjo probability (1) | Naranjo Probability Scale (1) |
Naranjo’s ADR probability scale (1) | Naranjo’s algorithm (1) | Narikel Lavan (1) |
Narrow therapeutic index drugs (1) | Nasal delivery (1) | Nasal gel (1) |
Nateglinide (1) | National Fomulary (1) | National Formulary (2) |
National Health and Morbidity Surveys (1) | National policy (1) | National Policy of Pharmaceutical Assistance (1) |
National Public Health Programs (1) | Natural (1) | natural compounds (3) |
Natural deep eutectic solvent (1) | Natural Polymers (1) | natural products (5) |
NCC-PvPI; Hepatitis B vaccine; ADR/AE; VigiFlow; system organ class (SOC) (1) | Nebivolol (2) | nebivolol hydrochloride (1) |
Necrosis. (1) | need assessment (1) | Neoplasm (1) |
Nepal (2) | Nephropathy (1) | Nephroprotective (4) |
Nephrotic syndrome (1) | Nephrotoxicity (1) | Nerium indicum (1) |
Network pharmacology (1) | Neurodegenerative diseases (1) | Neuronal development (1) |
neuropathy (1) | Neuroprotection (1) | Neuroprotective (1) |
Neurosurgical (1) | Neurotoxicity (1) | neutropenia (1) |
Neutrophil (1) | nevirapine (1) | new molecule (1) |
Newborns (1) | Nicorandil (1) | Nicotine (1) |
Nicotine dependence (1) | Nifedipine. (1) | Nigeria. (1) |
nigrostriatal pathway (1) | Nil (17) | Nill (19) |
Nimesulide (1) | niosome (1) | Niosomes (1) |
Nirmatrelvir (1) | Nitric acid (1) | Nitric oxide (5) |
Nitrogen starvation (1) | Nitroglycerin (1) | NK cell (1) |
NMDA (1) | NMDA receptors (1) | Noccik Kudinir (1) |
Nodular skin lesions (1) | Non-adherence (1) | Non-linear (1) |
Non-prescription medications (1) | non-prescription medicine use (1) | Non-steroid anti-inflammatory (1) |
Non-steroidal anti-inflammatory drugs (1) | Non-surgical endodontic therapy. (1) | nonamers. (1) |
noncommunicable disease (1) | noncompliance (1) | Nonionic surfactants (1) |
Nonomuraea longicatena (1) | nootropic (1) | Norfloxacin (1) |
Normoglycemic rats (1) | northeast India (1) | Nortriptyline HCl UV detection. (1) |
NOS (1) | Nose to brain delivery (1) | Nosocomial infections (1) |
Nothopanax scutellarium (1) | Novel delivery (1) | Novel drug delivery system (1) |
Novel Pyrimidines (1) | NPCB (1) | NSAIDs (3) |
Nuclear medicine (1) | nuclear pharmacy (1) | Nucleo CMP (1) |
Nude mice (1) | Nurses (1) | Nutmeg oil (1) |
Nutraceuticals (1) | Nutrient starvation (1) | Nutrition (1) |
Nystagmus Phenytoin toxicity (1) | O-Phenylene diamine (1) | Obesity (5) |
Occupational health (1) | Ocimum gratissimum (1) | Odontopediatric (1) |
Odorant binding Protein (1) | OECD (1) | Off-label (1) |
offending drugs (1) | Ofloxacin (1) | Okra Mucilage (1) |
Older people. (1) | Olmesartan (1) | olmesartan medoxomil (1) |
Omega-6 fatty acid (1) | Omeprazole. (1) | Omics (1) |
Oncology. (1) | Oncopharmacists (1) | ondansetron (3) |
ondansetron hydrochloride (1) | One health approach. (1) | Online health screening (1) |
Online pharmacies (1) | OPD – Outpatient Department. (1) | open field (1) |
Open field task (1) | Open field Tinospora cordifolia Linn (1) | Ophthalmic (1) |
ophthalmic delivery (1) | ophthalmic inserts (1) | Ophthalmology (1) |
Opinion (1) | Opportunities (1) | Opportunity (1) |
Opsoclonus myoclonus syndrome (OMS) (1) | Optimal stress (1) | optimization (9) |
Oral bacteria (1) | Oral cancer (3) | Oral cancer. (1) |
Oral diagnosis (1) | Oral disease (1) | Oral diseases (1) |
oral disintegrating tablets (1) | Oral glucose tolerance (1) | oral glucose tolerance test (3) |
Oral Health (1) | oral hygiene (1) | Oral hypoglycemic agents (1) |
Oral hypoglycemic drugs (1) | oral insulin (1) | Oral manifestations (1) |
Oral Medicine (1) | Oral potentially malignant disorders (1) | Oral Rehabilitation (1) |
Oral route (1) | Oral Surgery (2) | Orally disintegrating tablets (1) |
Organ Toxicities (1) | organic acids (1) | Organizational Culture (1) |
organogel (1) | Organophosphate (1) | ORIF (1) |
Origanum vulgare (1) | Original Article (3) | Originator. (1) |
Orlistat (2) | orodispersible tablet (1) | orodispersible tablets (2) |
Oscillopsia (1) | Osmotic pump (1) | Osseointegration (2) |
Osteoarthritis (3) | Osteoblast (3) | Osteoclast (2) |
Osteonecrosis (1) | Osteoporosis (1) | OTC switch (1) |
Otomycosis (2) | Outcome therapy (1) | Outdoor patients (1) |
Outpatient Pharmacy (1) | Outpatient Psychiatry (1) | Outpatients (1) |
Outside Pharmacy (1) | ovalbumin (1) | Ovarian (1) |
Ovarian Cyst (1) | Over dosage (1) | Over the counter (1) |
Over-the-counter (1) | Overweight (1) | OVX (1) |
Oxalic acid (1) | oxazepinone (1) | oxcarbazepine (1) |
Oxidation (1) | oxidative damage (1) | oxidative stress (6) |
Oxidative Stress. (1) | Oxyresveratrol (2) | oxytetracycline (1) |
P-dimethylaminobenzaldeyde (1) | P-drug. (1) | P-drugs (1) |
P-glycoprotein (1) | P. dulce (Fabaceae) (1) | p21SNFT (1) |
p53 tumor suppressor gene (1) | Package insert (1) | Paediatric (2) |
Paediatrics (1) | Pain (2) | Pain scale (1) |
Pain thresholds (1) | Pain. (1) | Painkiller (1) |
pair wise procedures (1) | Pakistan (3) | Pakistan. (4) |
Palbociclib (1) | Paliperidone palmitate (1) | Pancreatitis. (1) |
Pandemic (1) | Pantoprazole (1) | papain (3) |
Papain. (1) | PAR-2 receptor (1) | para-diaminobenzaldehyde (1) |
paracetamol (6) | Paracetamol. (3) | Paraneoplastic (1) |
Paresis (1) | Parkinson’s disease (2) | Partial coverage occlusal plaques (1) |
partial least square (1) | Particle Shape. (1) | particle size analysis (1) |
PASS (1) | passive avoidance learning (1) | Patch (1) |
patents (4) | Pathological response (1) | Patient (2) |
Patient adherence. (1) | Patient Care (1) | patient counseling (2) |
Patient counseling and Patient information leaflet (1) | Patient Counselling (1) | patient education (2) |
Patient health questionnaire (PHQ) (1) | Patient information leaflet (1) | Patient initiated adverse drug reporting (1) |
Patient Safety (3) | Patient satisfaction (2) | Patient Satisfaction Questionnaire (1) |
Patient Survival (1) | Patient-Pharmacist Intercommunication (1) | patient-physician communication (1) |
Patient-safety (1) | patients (4) | Patients. (1) |
paw edema (1) | Paw edema. (1) | Paw volume (1) |
PE 18:0/18:0-PEG 2000 (1) | Pectin (1) | pedagogy (1) |
Pediatric (3) | Pediatric cancer (1) | Pediatric Dentistry (1) |
Pediatrics (1) | Pediculosis (1) | Pegagan extract (1) |
PEGylation (1) | Pemphigus vulgaris (1) | Penang (1) |
penetration (3) | penetration enhancer (1) | penetration pressure (1) |
penicillamine (1) | Penicillins (1) | Pentazocine (1) |
pentylenetetrazole (1) | PEO (1) | Peperomia pellucida (L) Kunth (1) |
Peperomia pellucida (L.) Kunth (3) | Peppas and Higuchi’s equations (1) | Peppermint oil (1) |
Peptic Ulcer. (1) | peptide vaccine (1) | Peptidoglycan (1) |
percentage healing of wound area (1) | Percentage wound closure (1) | perception (11) |
Periauricular tags. (1) | pericyclic fiber (1) | Periodontal disease (1) |
periodontal diseases (1) | Periodontal dressing (1) | periodontal pocket (1) |
Periodontitis (1) | Peripheral Neuropathy (1) | Permanent (1) |
Permeation (5) | Permeation enhancer (1) | Peroxisome proliferator-activated receptorg (PPAR-γ) agonists (1) |
Persistent ulcer (1) | Personal care products (2) | Persons and items reliability (1) |
Petechiae (1) | pH dependent approach (1) | pH independence (1) |
pH-sensitive (1) | Phagocytosis (1) | Phaleria marcocarpha (1) |
Pharm. D. Integrated (1) | Pharm. D. Post Baccalaureate. (1) | pharma counseling (1) |
pharmaceutical (1) | pharmaceutical advertisements (1) | Pharmaceutical care (2) |
Pharmaceutical Care service (1) | pharmaceutical care. (1) | pharmaceutical formulations (1) |
Pharmaceutical Industry (1) | Pharmaceutical Marketing (1) | Pharmaceutical marketing. (1) |
Pharmaceutical packaging (1) | Pharmaceutical Sciences (1) | Pharmaceutical Services (2) |
Pharmaceutical-Care (1) | Pharmaceutical-industries (1) | Pharmaceutics (1) |
Pharmacist (6) | Pharmacist intervention (1) | Pharmacist intervention. (1) |
pharmacist role in public health (1) | Pharmacist. (1) | Pharmacists (2) |
pharmacists India (1) | Pharmaco epidemiology (1) | Pharmacodynamic (4) |
Pharmacodynamic activity (1) | pharmacodynamics (2) | Pharmacoepidemiology (1) |
Pharmacogenetics (1) | Pharmacogenomics (1) | Pharmacognostic (1) |
pharmacognostic standardization (1) | pharmacognostical (1) | Pharmacognosy (1) |
pharmacognosy study (1) | Pharmacokinetic (7) | Pharmacokinetic interactions. (1) |
Pharmacokinetic software (1) | Pharmacokinetic study (1) | pharmacokinetics (10) |
Pharmacokinetics. (2) | Pharmacological properties (1) | Pharmacophore (3) |
Pharmacosomes (1) | Pharmacotherapy (2) | Pharmacovigilance (22) |
Pharmacovigilance Programme of India (1) | Pharmacovigilance. (1) | Pharmacovigilante’s (1) |
Pharmacovigillance (1) | pharmacy (7) | pharmacy curriculum (2) |
Pharmacy education (1) | Pharmacy education. (1) | Pharmacy Enforcement Division (1) |
Pharmacy informatics (1) | Pharmacy intervention (1) | Pharmacy practice (2) |
Pharmacy services (1) | Pharmacy store (1) | Pharmacy student (1) |
Pharmacy students (3) | PharmD (1) | Phase diagrams (1) |
Phase I studies (1) | Phase rule (1) | phase solubility (1) |
phase solubility profile (1) | Phenobarbitone (1) | Phenolic (1) |
phenolic compounds (2) | Phenolic content (1) | phenolics (1) |
phenols (1) | Phenothiazine (1) | Phenytoin (7) |
Phenytoin cold cream (1) | Phenytoin Toxicity (1) | Pheretima and Anthelmintic (1) |
Pheritima posthuma (1) | Phleboliths (1) | Phoenix dactylifera (1) |
Phospholipid E80 (1) | Phosphorylase kinase (1) | Photocuring-Based Bioprinting (1) |
Photoprotection. (2) | Phthalates (1) | Phyllanthus emblica, (1) |
Phyllanthus reticulatus (1) | Phylogenetic tree (1) | Phylogeny (1) |
Physical activity (1) | Physical fitness (1) | Physical stability (1) |
Physichochemical Characterization (1) | Physicians (5) | Physicochemical (1) |
physicochemical evaluation (1) | physicochemical properties (1) | Physicochemical Tests (1) |
Physicochemical. (1) | physiochemical descriptor (1) | Physiological role (1) |
Phytochemical (2) | phytochemical prospection (1) | Phytochemical screening (2) |
Phytochemicals (1) | Phytoconstituents (1) | Phytomolecule (1) |
Phytopharmaceutical drug (1) | Phytosome (1) | picrotoxin (1) |
pictograms (1) | Pilgrims (1) | PIM (1) |
Pinus merkusii (1) | pioglitazone (1) | piperazine citrate (1) |
Piperidino thiophene (1) | Piperine (2) | Piroxicam (2) |
Pits and Fissures (1) | Pixel intensity. (1) | Placements (1) |
Plackett-Burman (1) | Plackett-Burman design (1) | plant extracts (1) |
plasma (3) | Plasma concentration (1) | plasma concentrations (1) |
Plasma creatinine (1) | Plasma glucose (1) | Plasma insulin (1) |
Plasma urea (1) | plasma-brain correlation (1) | Plasma. (1) |
Plasmodium falciparum 3D7 (1) | Plasmodium falciparum. (1) | Platelet (1) |
Platelet aggregation. (1) | Platelet concentrates (1) | Platelet rich fibrin membrane. (1) |
Pleiotropic effects (1) | PLGA (1) | PLS (1) |
PLSR (1) | Pluronic (1) | Pluronic F 127 (1) |
PM6 (1) | PM7 (1) | Pneumonia (2) |
POGIL (1) | Point-measure correlation coefficients (1) | Poison (2) |
Poisoning pattern (1) | Polarography (1) | Poloxamer 188 (1) |
Poloxamer 407 (2) | Poloxamer 407. (1) | poly (lactic-co-glycolic acid) (1) |
Poly herbal (1) | poly(ε-caprolactone) (1) | Poly-herbal (1) |
polycaprolactone (1) | Polycystic Ovary Syndrome (1) | Polyelectrolyte complex (PEC) (1) |
PolyElectrolytecomplex (1) | Polyethylene glycol (1) | Polyherbal (1) |
polyherbal formulation (3) | Polymer (1) | Polymeric nanoparticles (3) |
Polymorphism (1) | polypharmacy (8) | polypharmacy in diabetes mellitus. (1) |
polyphenols (1) | Polysaccharide (1) | polyvinyl alcohol (2) |
polyvinyl pyrrolidone (1) | Polyvinylpyrrolidone (1) | Polyvynil pyrrolidone (1) |
Pomalidomide (1) | PON1 mRNA (1) | porosity (1) |
Port-A Catheter. (1) | Portfolio (1) | Positive and Negative stressors (1) |
Positive coping strategies. (1) | Posology (1) | Possible mechanisms (1) |
Post marketing (1) | Post SARS-COV-2 infection (1) | Post-antibiotic era (1) |
Posterior reversible encephalopathy syndrome (1) | Postpartum depression/Postnatal depression (1) | Potassium (1) |
Potassium Channel (1) | Potassium chloride (1) | Potassium Nitrate (1) |
Potential Drug-Drug Interaction (1) | Potentially malignant lesions (1) | POTS (1) |
Powder (1) | PPAR agonists (1) | PPARγ agonists. (1) |
PPBG (1) | pPharmacokinetics (1) | PPP model (1) |
practice (5) | practices (1) | pravastatin (1) |
Pre ADMET (1) | pre prandial (1) | Pre University students (1) |
Pre-authorization (1) | Pre-Exposure Prophylaxis (1) | Pre-school (1) |
Prebiotic (2) | Preceptors (1) | Precipitation (1) |
precise (1) | Precision (1) | Predictors (3) |
Pregabalin (1) | Pregnancy (5) | preliminary screening (1) |
Premna esculenta (1) | Preparedness (1) | prescriber (1) |
Prescribing (2) | Prescribing errors (2) | Prescribing indicators (1) |
Prescribing pattern (3) | Prescribing pattern and Prescription Quality (1) | Prescribing pattern. (1) |
Prescribing Trend (1) | Prescription (3) | Prescription audit (1) |
Prescription error. (1) | prescription monitoring (1) | prescription only medicines (1) |
Prescription pattern (3) | Prescription patterns (1) | Prescription refill (1) |
Prescription review (1) | pressure dependent approach (1) | Prevalence (6) |
Prevalence. (1) | Prevention (1) | Prevention. (1) |
Price variation (1) | Primary dentition. (1) | Primary health care (2) |
Primary Health Care. (1) | Primary tooth (1) | Principal component analysis (1) |
principal component regression (1) | Pristane (1) | Private Medical College (1) |
Private sector (1) | PRO (1) | Probable (1) |
Probiotic (1) | Probiotics (2) | Problem-based learning (1) |
process capability (1) | Process parameters. (1) | Product Surveillance (1) |
Products with Antimicrobial Action. (1) | progesterone (1) | Proniosomal gel (1) |
Property Intellectual (1) | Prophylaxis (2) | propolis (5) |
Proportional reporting ratio (1) | propranol hydrochloride (1) | Propranolol hydrochloride (1) |
Prospection (1) | Prospective (1) | Prospective Study (2) |
prostaglandins (1) | Prosthesis Coloring (1) | Proteasome activity (1) |
protein proÞ le (1) | proteolytic enzymes (1) | Proton adduct (1) |
Proton Pump Inhibitor (2) | Proton pump inhibitors (1) | Proton-pump Inhibitors (1) |
Protransfersome (1) | Prteomics (1) | Pseudo ternary phase diagrams (1) |
Pseudomonas aeruginosa (1) | Psidium Guajava (1) | Psychiatric distress (1) |
Psychiatric illness (1) | Psychiatric patients (1) | Psychiatric treatment (1) |
Psychological factors (1) | Psychological mindedness (1) | Psychomotor (1) |
Psychosis (2) | Psychosis. (1) | Psychotropic drugs (1) |
Psychotropics (1) | Pterocarpus indicus (1) | Pterocarpus indicus Willd (1) |
Public behavior (1) | Public health (1) | Public health hospital (1) |
Public hospital (2) | Public Service (1) | Publication (1) |
Publications (7) | Pulmonary Fibrosis (1) | pulmonary hypertension (1) |
Pulmonary toxicity (1) | Pulpectomy (1) | Pulse wave velocity (1) |
Punica granatum (2) | Pyrazinamide (1) | pyrazine (1) |
pyrazoline (1) | pyrazolines (2) | Pyrimidine (1) |
Q1F (1) | QOL (1) | QRS-T angle (1) |
QSAR (3) | qualitative (1) | Qualitative analysis (1) |
Qualitative research (1) | qualitative study (1) | Quality (2) |
Quality Assessment (1) | quality assurance (1) | Quality by design (QbD) (1) |
Quality by design Ritonavir (1) | Quality Control (1) | Quality Indicators (1) |
Quality of Health Care (1) | quality of internet information (1) | quality of life (10) |
Quantification (1) | quantitative structure-activity relationship (1) | Quercetin (2) |
Questionnaire (2) | Questionnaire. (1) | quinazolin-4(3H)one (1) |
quinazolinone (1) | Quinazolinone. (1) | quinoline derivatives (1) |
R2 values (1) | Rabbit plasma (1) | Rabbits. (1) |
radical scavenger (1) | Radical scavengers (1) | radicals (1) |
Radiculopathy (1) | Radio-mitigation (1) | Radiology Unit (1) |
radiopharmaceuticals (1) | radiopharmacy (1) | Radioprotective (1) |
Raillietina echinobothrida (1) | raloxifene hydrochloride (1) | Raltegravir potassium (1) |
Raman spectroscopy (2) | ramipril (2) | ranitidine (1) |
Ranitidine hydrochloride (2) | Ranitidine’. (1) | ranolazine (1) |
Ransmission electron microscopy (1) | Rapid antigen test (1) | Rapid disintegration (1) |
Rasagiline mesylate (1) | Rat (1) | ratio test procedures (1) |
Rational pharmacotherapy. (1) | Rational prescribing (1) | Rational Use (2) |
Rational use of Medication (1) | Rational use of medicine (1) | rational use of medicines (1) |
rats (1) | Rattus novergicus (1) | Re-emerging viral infections (1) |
re-precipitation (1) | Reactants (1) | Recent trends (1) |
recognized standards (1) | recovery studies (1) | Recurrent oral ulcer (1) |
Red ginger (1) | Reduction (1) | Reflective pedagogy paradigm (1) |
Reflux diseases (1) | reforms (1) | Regeneration (1) |
RegiSCAR score. (1) | Regression analysis (2) | Regressions statistics (1) |
Regulation (1) | Regulations (1) | regulatory (2) |
Regulatory affairs (1) | regulatory system (1) | Rehospitalisation (1) |
Related substance (1) | Relative performance (1) | release kinetics (3) |
Release studies. (1) | relese kinetics (1) | Removable denture (1) |
Renoprotection (1) | Renoprotective (1) | Renovascular hypertension (1) |
repaglinide (2) | reperfusion (1) | Repurposing (1) |
research (1) | Research impact (2) | Research output (1) |
Research Skills. (1) | reserpine (1) | Resident doctors (1) |
Resistance (6) | Resistance. (1) | Resistant starch (1) |
Resource poor setting (1) | Respiratory failure (1) | Respiratory tract (1) |
Respiratory troubles (1) | Response Surface Methodology (3) | Response surface methodology. (1) |
Response to antiretroviral therapy (1) | Resveratrol (2) | retail pharmacy (1) |
Retention. (1) | Retinopathy (1) | retrospective cohort (1) |
Retrospective study (4) | reversed-phase chromatography (1) | Review (1) |
Rhabdomyolysis (1) | Rhaphidophora pinnata (1) | Rheumatology (1) |
rhizomes (1) | Riboflavin (1) | Rice Bran Oil (1) |
Rifampicin (2) | Ringer’s dextrose (1) | Ringer’s lactate. (1) |
Riociguat (1) | Risk (1) | Risk Estimation Matrix (1) |
Risk factor. (1) | Risk factors (6) | Risk Factors. (1) |
Risk Groups (1) | Risk Management. (1) | Risk rating (1) |
Risk-factors (1) | Rituximab (1) | rivastigmine (1) |
RNA interference (1) | RNAi (1) | RNAi technology (1) |
RNTCP (2) | ROB (1) | Rodenticides (1) |
root (1) | Root canal filling materials (1) | Root canal infection (1) |
Roots extract (2) | Ropinirole (1) | Roscoea purpurea (1) |
rosuvastatin (2) | rosuvastatin calcium (1) | Rota rod test (1) |
Royal Malaysian Custom Officer (1) | RP-HPLC (10) | RP-HPLC method (1) |
RP-TLC/Densitometry (1) | RP-UFLC method (1) | RT-qPCR (1) |
Rubus fraxinifolius (1) | Rubus rosifolius (1) | rupatadine (1) |
rutin (1) | ß avonoids (2) | S. mutans (1) |
S.salivarius (1) | S.sanguis (1) | Saccharin (1) |
Safe handling guidelines (1) | Safety (2) | Safoof razyanaj (1) |
Safoof-e- Binai (1) | Sage (1) | Saliva (2) |
Sambung nyawa (1) | Sangunine. (1) | Saponin (2) |
saponins (1) | Sappan wood (1) | Saraschandra (1) |
SARS-CoV-2 (5) | Satisfaction (2) | Saudi Arabia (10) |
Saudi Arabia. (2) | Saudi National Pharmacovigilance Centre (Saudi NPC) (2) | Saussurea (1) |
Saussurea lappa (1) | SBVS (1) | Scale (1) |
Scale for the assessment and rating of ataxia. (1) | scanning electron microscopy (3) | Schizophrenia (3) |
Scientific Advertisements (1) | Scientometrics (13) | Scientometrics. (8) |
Scientometrics1. (1) | sclerotherapy (1) | Scopolamine (1) |
Scores. (1) | Scorpions (1) | Se- DeM ODT Expert system (1) |
Second-line agents (1) | Secondary Level (2) | Sedation (1) |
Sedation in pediatric patients (1) | Sedation scale (1) | seizure outcome (1) |
Seizures (1) | seizures. (1) | Selected area electron diffraction (1) |
Self efficacy. (1) | Self medication (1) | Self-directed learning (1) |
self-emulsifying drug delivery system (1) | Self-Harm (1) | self-medication (7) |
Self-Nano Emulsifying Drug Delivery System (SNEDDS) (1) | self-nanoemulsification (1) | Selfmedication (1) |
Semi-permanent hair dye (1) | senna spectabilis (1) | Sensitive (1) |
sensory cortical activity. (1) | separation (1) | sepbox (1) |
Septic shock (1) | Sequences distillation (1) | Sequential optimization (1) |
Serum (1) | Serum Ferritin (1) | Serum Glutamate-Pyruvate Transaminase (1) |
Serum Glutamic Oxaloacetic Transaminase (1) | Serum triglyceride (1) | Serum Vitamin D (1) |
Serum. (1) | sesame oil (1) | Severe acute respiratory syndrome coronavirus 2 (1) |
Severe acute respiratory system coronavirus 2 (1) | severe febrile neutropenia (1) | Severe Neck Pain (1) |
Severe sepsis (1) | Severity (2) | Sexual dysfunction in diabetes (1) |
Sexuality (1) | SF-36 (1) | SG-alcohol. (1) |
SG-Chloro (1) | SGLT-2 Inhibitor (1) | SGLT2 Inhibition (1) |
Shark liver oil and Wound healing activity (1) | Shodhana (1) | Short Communication (3) |
short-term memory (1) | Sida rhombifolia (1) | Sida rhomboidea.Roxb (1) |
Side effect (1) | Side effects (1) | signal detection (1) |
Signal detection. (1) | Signs and Symptoms (1) | Signs and Symtoms (1) |
Silver nanoparticles (1) | silymarin (2) | Silymarin. (1) |
Similarity factor (1) | similarity factor (f2) (2) | simplex lattice (1) |
Simplex Lattice Design (2) | Simultaneous Delivery (1) | simultaneous determination (2) |
simultaneous extraction (1) | simvastatin (1) | simvastatin. (1) |
Single dual anticoagulant therapy (1) | Single nucleotide polymorphism (1) | Single-dual-triple antiplatelet therapy (1) |
sintering (1) | siRNA (1) | siRNA. (2) |
SIRT1 (1) | Sirtuin (1) | Sitagliptin (1) |
Sitagliptin phosphate (1) | six sigma (1) | SJS (1) |
Skin diseases (1) | Skin drug test (1) | Skin irritation (1) |
Skin protection (1) | Skin whitening (1) | SLAM markers (1) |
Sleep disorders (1) | SLS (1) | Smix (1) |
Smix. (1) | Smoking (1) | smoking cessation. (1) |
Smoking. (1) | smooth muscle cells (1) | Snake bite (1) |
SNEDDS (2) | sobatum (1) | Social Media (1) |
Social network analysis (1) | Social sexual. (1) | Sociodemographic factors (1) |
Socioeconomic status (1) | SOD (1) | Sodium (1) |
sodium alginate (1) | sodium alginate. (2) | sodium carboxy methyl cellulose (1) |
sodium starch glycolate (3) | Sodium starch glycolate (SSG) (1) | Sodium Valproate (1) |
Sofosbuvir (1) | Solanum giganteum (1) | Solanum nigrum (1) |
Solanum surattense (1) | Solanum trilobatum (1) | Solanum viarum (1) |
Solanum xanthocarpum, (1) | Solasodine (1) | solid dispersion (5) |
solid lipid nanoparticles (1) | Solid lipid nanoparticles. (1) | Solid Phase Extraction (1) |
solubility (8) | Solubility enhancement (1) | Solubility. (1) |
solvent casting (1) | solvent evaporation (4) | Solvent evaporation. (1) |
sonication time (1) | sonophoresis (1) | Sorafenib (1) |
Sources (1) | South Asia (1) | Spacedrepetition. (1) |
spasmolytic (1) | speciÞ city (1) | Spectrometric (1) |
spectrophotometry (2) | sperm count (2) | SPF (1) |
Spiro compounds (1) | Spleen colony assay (1) | Spondylosis (1) |
Sponge implantation (1) | sponge implantation assay (1) | sponsors (1) |
Spontaneous-Reporting. (1) | Sprague Dawley (1) | spray drying (1) |
SPSS 20. (1) | Sri Lanka (2) | ST segment elevation (1) |
stability (4) | stability indicating (1) | stability indicating and validation. (1) |
Stability indicating assay (1) | Stability indicating assay method (1) | stability indicating method of artemether (1) |
stability indicating. (1) | Stability of the physical properties (1) | Stability test (1) |
stability. (1) | stain removal (1) | stakeholders (1) |
Standardization (7) | Standardized Zscore (1) | Staphylococcus aureus (1) |
Staphylococcus sciuri (1) | Starlac (1) | Statin pathway (1) |
Statins. (1) | Statistical Modeling (1) | Statistical optimization (1) |
Stelechocarpus burahol (1) | Stem bark extract (1) | Stephania hernandifolia (1) |
Stereospermum suaveolens (1) | Stereospermum tetragonum (2) | Sterilization Procedures (1) |
Steroidal alkaloid (1) | Steudnera colocasiifolia (1) | Stevens Johnson Syndrome (1) |
Stevens-Johnson syndrome (1) | Stilbene (1) | Stimulantia (1) |
Stimuli (1) | Stomatitis under prosthesis (1) | Strabismus surgery (1) |
Streptococci (1) | Streptococcus mutans (4) | Streptokinase (1) |
Streptomonospora arabica (1) | Streptomyces (1) | Streptozotocin (2) |
Streptozotocin (STZ) (1) | streptozotocin-induced diabetes (1) | Streptozotocin. (1) |
stress (3) | Stress degradation (1) | stress studies (2) |
Stroke (1) | stroke and cardiac pacemaker. (1) | Stroke prevention (1) |
structural descriptor (1) | Structured Communication. (1) | Stryphnodendron rotundifolium (1) |
students (4) | Students. (1) | students’ residence (1) |
Sub Clinical Hypothyroidism. (1) | Sub-acute Inflammation (1) | Subarachnoid hemorrhage (1) |
Subcutaneous fat (1) | sublingual films (1) | substituted acetophenones (1) |
Succinic acid (1) | sucrase (1) | Sudan (1) |
Sulfated polysaccharides (1) | Sulfonylurea (2) | Sulfonylureas (1) |
Sulphorhodamine-B (1) | Sun (1) | sun protection factor (2) |
Sunlight (1) | Sunscreens. (1) | Super disintegrants (1) |
superdisintegrants (2) | Superdisintergrants (1) | Superoxide Dismutase. (1) |
superoxidedismutase (1) | superporous hydrogel composite (1) | Supply Chain Management (1) |
support staff. (1) | Supportive care (1) | Surface properties (1) |
surfactant (1) | surfactants (2) | Surgery (2) |
Surgical cutters (1) | surgical prophylaxis. (1) | Surgical. (1) |
Survey questionnaire (1) | survey. (1) | Survival rate (1) |
sustained release (3) | sustained release pellets (1) | sustained release. (1) |
Susutained release layer (1) | Sweet orange peel extract (Citrus sinensis) (1) | swelling index (2) |
swelling studies (1) | SWOT (1) | Symptom (1) |
Symptoms (1) | Symptoms domain (1) | Synchronous spectrofluorimetry. (1) |
Synergism. (1) | Synthesis (4) | Synthesis; 1-allyl-3-benzoylthiourea; COX-2; Analgesic; Lead Compound; (1) |
Systematic review (2) | Systematic Review. (1) | Systemic Inflammatory response (1) |
Systemic steroids. (1) | Systems biotechnology (1) | Systolic dysfunction. (1) |
T cell epitope (1) | T lymphocytes (1) | T regs (1) |
T2DM (1) | Tab. Pardopa (1) | Tablet Compression (1) |
Tablet splitting (1) | Tacrolimus (2) | Tacrolimus Once Daily (1) |
Tacrolimus Twice Daily. (1) | Tactile stimulation (1) | tail suspension test (1) |
Takayasu arteritis. (1) | Tamarindus indica (1) | Tamilians (1) |
Tamoxifen (1) | Tampering (1) | Target delivery (1) |
Targeted drug delivery system (1) | taste masking (2) | tasteless complex (1) |
taxane (1) | Taxanes (1) | Taxus baccata (1) |
Teaching Hospital (1) | Technology (1) | technology-enhanced learning (1) |
Tecoma stans (1) | tegument (1) | telmisartan (1) |
Temporomandibular Joint (1) | Temporomandibular Joint Disoders (1) | TEN (1) |
Tenatoprazole sodium (1) | Tengger (1) | Tenofovir disoproxil fumarate (1) |
Tephrosia purpurea ethanolic seed extract (TpEt). (1) | Tephrosia villosa (1) | Terminala bellerica (1) |
Terminalia bellirica (1) | Termineliachebula;Plants; Galls;Albendazole; anthelmintic; Drug. (1) | Ternary phase diagram (1) |
terpenoids (1) | Tertiary Care (1) | Tertiary care hospital (3) |
testicular damage (1) | testosterone (3) | Tetrapreniltoluquinone (1) |
thalassemia major (1) | therapeutic angiogenesis (1) | therapeutic dose (1) |
therapeutic drug monitoring (2) | therapeutic effectiveness (1) | Therapeutic Policies (1) |
Thermoreversible gel (1) | Thiazolidinone (1) | Third Molar (1) |
Thixogel (1) | Thixotropic (1) | THP-1 (2) |
Three component system (1) | thrombocytopenia (1) | Thrombolysed subjects (1) |
Thrombolytic (1) | thrombolytic enzymes (1) | Thrombophlebitis (1) |
Thunderclap Headache (1) | Thyme oleoresin (1) | Thyroid diseases (1) |
Thyrotoxicosis. (1) | Tigecycline (1) | time dependent approach (1) |
Time lag (1) | Timed release (1) | Tissue distribution (1) |
Tityus (1) | TLC (1) | TNF-α (1) |
Tobacco (2) | Tobacco smoking (1) | tolbutamide (1) |
Tolerance (1) | Tooth brush. (1) | Tooth brushing (1) |
Tooth Demineralization (1) | Toothbrushing (1) | Toothpaste (1) |
Toothpaste. (1) | Topical delivery. (1) | Topical drug delivery system (1) |
Topical herbs (1) | Topical treatment (1) | Topical. (1) |
Total flavonoid (1) | Total flavonoid content (2) | Total phenolic (2) |
Total phenolic content (1) | total polyphenolic content (1) | total quality management (1) |
toxicity (5) | Toxicity. (2) | traditional medicine (2) |
Training of Central sterile and supply department employees (1) | tramadol HCL (1) | Tramadol Hydrochloride (1) |
Trans-cinnamic acid (1) | Trans-resveratrol (1) | Transcriptomics. (1) |
transdermal (2) | transfer latency (1) | Transfersome (2) |
Transfersomes (1) | Transfersomes. (1) | Translation (1) |
Transmucosal (1) | Transmucosal patch (1) | Trauma induced external inflammatory root resorption (1) |
Treatment (2) | Treatment adherence. (1) | Treatment outcomes (1) |
Treatment success rate (1) | Triacylglycerol. (1) | Triamcinalone Acetonide (TRIA) (1) |
Trichoderma reesei. (1) | Tricyclic antidepressants (TCA) (1) | Triglycerides (1) |
Trigonella foenum graecum (1) | Trigonelline (1) | Trinidad & Tobago (1) |
trinitrobenzene sulfonic acid (1) | Triphala (2) | triple distilled water (1) |
Triterpenoid. (1) | Triterpenoids (1) | Triticum aestivum. (1) |
Tropaeolum majus L (1) | tropicamide (1) | Troponin-I (1) |
Trypsin (1) | TSLP (1) | Tuberculosis (5) |
Tuberculosis/HIV (1) | Tukhm-e-soya (1) | Tumor response (1) |
Turkey (1) | Turmeric (1) | Turpentine oil (1) |
Tween 80. (1) | Twisted (1) | Tylophora indica (1) |
Tylophorinidine. (1) | Type 1 Diabetes (1) | type 2 diabetes (2) |
Type 2 diabetes mellitus (1) | Type 2 diabetes mellitus. (1) | type 2 diabetes. (1) |
Type II Diabetes (1) | Type-1 Diabetes (1) | UACR (1) |
UCPMP Guidelines (1) | Ultra violet detection (1) | Ultra-Fast Liquid Chromatography (UFLCDAD) (1) |
Ultrasonic assisted extraction (1) | ultrasonication-solvent evaporation technique (1) | Ultrasonography (1) |
Unani (1) | Unani Medicine (1) | Unani medicine (5) |
Uncemented (1) | Underutilization of insulin. (1) | Unethical practices. (1) |
Unique device identification (1) | Universal health coverage (1) | Universities (1) |
Unlicensed. (1) | Unnecessary use. (1) | Unused drugs (1) |
Unused/Unwanted medicines (1) | UPLC-QToF-MS/MS (1) | UPLC/ESI-Q-TOF-MS/MS method Validation (1) |
Urban area (1) | urea (2) | Uremic toxins (1) |
Urinary Hydrogen Peroxide (1) | Urinary Tract Infection (1) | Urinary tract infection (UTI) (1) |
Urine Albumin to Creatinine Ratio (1) | Urine volume (1) | urolithiasis (1) |
Urtica dioica L (1) | URTIs (1) | Usefulness. (1) |
Uterine fibroid (1) | Uterine fibroids (1) | Uterine Perforation. (1) |
Utilization Pattern (1) | UV derivative spectrophotometry (1) | UV detection (2) |
UV Spectrophotometric method (1) | UV spectrophotometry (2) | UV Spectroscopy (1) |
UV-spectrophotometric method (1) | UV-spectrophotometry (2) | UV-Vis spectroscopy (1) |
Vaccine (3) | Vaccine design (1) | vada (1) |
vaginal gel (1) | Vaginitis. (1) | Vakrasana (1) |
validation (21) | Validation. (1) | Valium (1) |
Valproate (1) | valsartan (1) | Vanillin (1) |
Vanillosmopsis arborea. (1) | vascular bundle (1) | vascular permeability (2) |
vascular progenitors (1) | VED analysis (3) | VED analysis. (2) |
VEGFR-2 (1) | Velpatasvir (1) | Venetoclax (1) |
Venography and Hemangioma (1) | Venous malformations (VMs) (1) | verapamil (3) |
Verapamil HCl (1) | Viability (1) | Vincristine. (1) |
Vinegar (1) | VIPPS (Verified Internet Pharmacy Practice Sites) (1) | Virtual Screening (1) |
Viscosity (1) | visible Spectrophotometry (1) | visible spectroscopy (1) |
Visual analogue scale. (1) | Visual Analogues Score. (1) | Vitamin B12 (1) |
Vitamin B6. (1) | Vitamin D (3) | Vitamin D deficiency (3) |
Vitamin D. (1) | vitamin E (1) | vitamin E d-α-tocopheryl polyethylene glyco1000 succinate (1) |
Vitamin. (1) | Vitamins (1) | Vitex agnus Castus (1) |
Vitex negundo (1) | Vitex negundo Linn (1) | Voltage–gated calcium channels (1) |
Voriconazole (1) | Wabā (1) | warfarin (2) |
Warning signs (1) | Water hyacinth (2) | web-based learning (1) |
Weibull parameters (1) | West timor (1) | Western blot technique (1) |
Wet gangrene (2) | wet granulation (2) | Wetting Property (1) |
wetting time (1) | Wheat (1) | White/red patch (1) |
WHO BREF QOL (1) | WHO core indicators (1) | WHO prescribing indicator (1) |
WHO-QOL BREF questionnaire (1) | WHO-UMC causality assessment system. (1) | Wilson disease (1) |
Wistar rats. (1) | Withania somnifera. (1) | Withdrawal (1) |
Women. (1) | Work protection (1) | Work Satisfaction (1) |
World Anti-Doping Agency (1) | World Health Organization (1) | Worldwide (1) |
Wound care (1) | Wound Healing (1) | Wound tissue healing (1) |
Woundhealing. (1) | Wrightia tinctoria (1) | writhing (1) |
X-ray diffraction (1) | X-ray imaging study. (1) | X-ray powder diffraction (1) |
xanthan gum (1) | Xanthangum (1) | XDR-TB (1) |
Xenografts (1) | Xenografts. (1) | XRD (1) |
Xylitol (2) | Ylang-ylang (1) | Yoga (1) |
Young (1) | Yucca gloriosa L. (1) | Zea m1 pollen allergen (1) |
Zero order release (1) | zero order spectrophotometry (1) | zeta potential (1) |
zidovudine (2) | Zika virus (1) | Zikavirus Infection (1) |
zinc (1) | Zinc ion (1) | Zingiber officinale (1) |
Zingiberaceae (1) | zopiclone (1) | [BMIM]PF6 (1) |
Þ rst-order derivative spectroscopy (1) | Α-amylase (3) | α-glucosidase (2) |
α-mangostin (1) | α1 adrenergic antagonist (1) | β amyloid protein (1) |
β Amyloid1-42 (1) | β-carboline (1) | β-carotene production (1) |
β-cyclodextrin (3) | γ-oryzanol (1) | γ-retroviral vector (1) |
ε-amino groups (1) | | |